375 - The ketogenic diet, ketosis, and hyperbaric oxygen: weight loss, cognition, cancer, and more
3959 segments
Hey everyone, welcome to the Drive
Podcast. I'm your host, Peter Aia.
Hey Dom, thank you for making the trip
out to Austin. It's uh boy, it has been
a long time since we've been in person.
I I'm I'm afraid to uh to hazard a guess
as to when, but I know you and my
brother see each other a lot more, and
I'm always getting pictures of you
visiting him and him visiting you.
>> Yeah. Yeah. Paul's amazing. Yeah, he uh
he's a mentor to me and as you are in
through the health and Paul's like an
amazing you know entrepreneurial mentor
and a life mentor in many different
ways. So but great to see you both and
uh you guys are such you know uber high
achievers in different domains and I
think it's great to see you know it's
great to see you in person for one thing
but it's great to see both of you thrive
in doing what you do. Well, the same can
be said for you. Um, Dom, you've been on
this podcast a couple of times, but I I
know that in podcast land, uh, it's a
we've probably got, you know, hundreds
of thousands of listeners today that
weren't listeners, you know, the first
and second time you were on the podcast.
Um, and frankly, those that were, I
think it would be understandable that
they've forgotten most of what we've
spoken about. Um, and maybe just by way
of background, I'll I'll let folks
understand how how you and I connected.
I believe Ken Ford connected us back in
2011ish
thereabouts. Um, at the time I had was
about a year into experimenting with a
ketogenic diet. Um, having all sorts of
interesting success with it for the most
part once I once I got over the hump of
figuring out how to do it. Um, and I
think we must have connected at uh at
his institute and then the rest is kind
of history. We we then through our
friendship became very uh deeply
involved in the testing of the earliest
generations of um various forms of
synthetic ketones. A topic we will
undoubtedly get to today because it's
impossible to imagine how much
proliferation there has been of these
things that were I mean literally you're
sending me like dirty plastic bottles
with stuff in my kitchen that I'm
experimenting with and and it's like now
look at what you've done. Um so maybe
let's just talk a little bit about how
your interest in this space came to be.
So um for for even for my recollection I
don't recall your PhD was in
neuroscience if I'm not mistaken.
>> Yeah. Uh nutrition and then at the time
studying nutrition and biology I started
doing u a undergraduate thesis project
in neuroscience and the neural control
of autonomic regulation. So specifically
the brain network the rostal vententral
lateral medela. So they are the brain
stem network that controls respiration
uh so inspiratory neurons expatory
neurons and how they respond to oxygen
and uh CO2 and that led me down the path
of oxygen hypoxia hyperoxia hypercapneia
extreme environments and what what
happens to the brain under oxygen
deprivation and nutrient deprivation. At
the time I was interested in alpha L
polyactate because it was in cytoax
which was something I used because I
race mountain bikes. So I was testing
some things uh lactate and then I got
steered onto the ketogenic diet. uh
after getting a fellowship a a post-doal
fellowship by the office of navy
research which is part of the department
of defense to understand the cellular
and molecular mechanisms of central
nervous system oxygen toxicity which
manifested seizures. So I was mostly
interested in drugs but then I pivoted
and went back to the ketogenic diet
because the ketogenic diet works for
many different seizure disorders when
drugs fail. So I was like, "Oh, I can
get nutrition back." Although I was
gravitating towards a tenure track
position and everybody told me this is
like the dumbest thing to do to like you
can't get NIH funding with, you know,
ketogenic. Nobody heard of the ketogenic
diet.
>> What year was this? Uh this was around
200 uh five I started tinkering with
ketones but 2007 I started writing
grants and then I hit on a grant in 2008
like post-doal uh grant and I was I had
a weird position from posttock to
something called a research assistant
professor which is like an intermediate
position before you get into a tenure
track and the university was just kind
of gauging to see my productivity and uh
as my post-docctoral grant was very
sizable it was above like an NIH level
grant which I was getting and it paid
full indirects for that and we can talk
about you know
>> and that came from the military.
>> Yeah. Office of Navy research as part of
the department of defense and then uh
and then I got good data on hyperbaric
atomic force microscopy very mechanistic
research. I also did patch clamp
electrophysiology and conffocal
microscopy.
uh my work was really focused on redux
mechanisms and looking at super oxide
production undergraded levels of oxygen
and different different metabolites.
So in the process of doing all that I
had no interest in cancer but we had
some glyobblastoma cells and we threw
them into the hyperbaric chamber and
under uh under conffocal microscopy we
could see the mitochondria were lighting
up and then kind of exploding or
disappearing uh in the cancer cells and
that was kind of unique and uh and that
led me on a side tangent thing to study
cancer but my central thing that I
studied was neuroscience and I've always
I've been in neuroscience department and
just mainly focused on that.
>> Let's go back to something you said at
the outset just because folks might not
understand why the Navy would be
interested in the effects of too much
oxygen, right? When you think of the
Navy, you think of being underwater.
When you think of being underwater, you
think of oxygen deprivation. So, what is
it about certain types of diving that
actually bring about the opposite
problem?
>> Yeah, good question. Uh so hyperaric
oxygen you experience that with
hyperbaric oxygen therapy right and
there's 14 different FDA approved
applications and that you in that
context you only go to about a maximum
of 2.5 to three atmospheres of pure
oxygen in the context of military diving
like a Navy Seal use a closed circuit
rebreather because there's no bubbles so
there's a stealth component to that and
you're breathing uh high concentrations
of oxygen And at at 50 feet of seawater,
the potential for oxygen toxicity
exists.
>> And just explain tools. Sorry, Don.
Explain to folks exactly what that is.
So, how does a rebreather work? What's
the concentration of oxygen that they're
breathing in?
>> Yep. So, uh a closed circuit rebreather
for example, like a drager rebreather
like the original ones, uh those early
rebreathers and even now it's high
concentration. It's like a essentially
100% oxygen, right? You're breathing
100% oxygen. So there's no nitrogen.
There's 80% nitrogen air we're breathing
right now, right? Uh there's no
nitrogen. So you avert the potential for
nitrogen narcosis. So nitrogen's not
narcotic at one atmosphere, but there
you get something called the martini
effect. And as you go down lower,
nitrogen becomes narcotic. So that's
something else that we study. But uh so
you're breathing 100% oxygen and uh and
then there's a CO2 scrubber. So you're
blowing out the exhaled carbon dioxide
is scrubbed out from the breather and uh
and that keep it's a closed circuit. So
there's no offging associated with uh
scuba diving or even other types of uh
technical diving where you have some
offging, right?
>> And the reason that they can do that is
because you're not wasting gas on the
80% nitrogen. You basically you're you
basically just have to store the CO2
that's coming out once you've scrubbed
it. you've got pure O2 coming in. So
your title your your volume of air
needed is much lower cuz you're just
solving for the oxygen.
>> That's part of it because the oxygen
tanks are are pretty small, right, with
a rebreather. But uh it's analogous to
uh we have a couple ponds on our
property, right? And I I uh when I go in
the pond and uh and I see bubbles coming
across the pond, I know an alligator is
coming towards me, right? So that's how
I when your brother was there, we were
like we were looking at the alligators
and and just uh getting them to come to
us by throwing pebbles in there when
they hear something. So if I go to the
lawn to the pond with a weed whacker, I
see bubbles coming across. So analogous
situation would be a Navy Seal coming
across a body of water that's still you
can clearly see the bubble trail coming
to you. So with a a closed circuit
rebreather that completely averts that
the bubble trail and then there's also
the noise that the bubbles make, right?
So you don't have that. The problem is
if you're wearing a closer and you dive
down to a 100 like 100 feet of seawater
because someone starts shooting at you
or you have to go down deep to put a
mine on the bottom of a bridge or
something like that, you're going to
have a seizure within like 5 minutes. So
oxygen is a stimulant. It stimulates a
massive amount of uh glutamate release
that activates amperceptors, NMDA
receptors. uh it stimulates the neural
network um in ways. It also sort of
deactivates or inhibits an enzyme
glutamic acid decarbox which converts
more glutamate to GABA. So there's like
uh a and there's a big burst in reactive
oxygen species. So you have a
constellation of things going on in your
brain. So I study the negative effects
of high high oxygen which kind of has
some people who study hyperbaric oxygen
a little bit standoffish towards me
because I study the but in the context
of lower oxygen oxygen uh hyperbaric
oxygen therapy can be very therapeutic
and
>> I do want to talk about that. So um
there's a lot I want to ask you about
hyperbaric oxygen but I want to finish
the swing on this particular
application. When was it clear to the
Navy the problem that you described,
which is when we have um closed circuit
rebreathers with 100% oxygen, we're
running into problems with our divers.
And it these problems are dramatic. I
mean, if you have a seizure at 100 feet,
you're going to die pretty quickly. So,
when when did they come to realize this?
And and how is this was this a
relatively recent discovery?
>> No, it's not. And my mentor, Dr. J.
Dean, our lab is like a museum. So we
have all the historic pictures on there
and there's a guy that wrote a book and
his name was Fred Bear and uh he was a a
French physiologist and uh he did a lot
of seinal studies back you know over
well over a hundred years ago in the
1800s showing that like you could give
animals uh they called it like uh
quesons disease too. So that could when
you go down in like chambers when you're
building a bridge you're under high
pressure oxygen or high atmospheric uh
effects. So yeah, I would say about 150
years ago, we realized that oxygen was a
stimulant. We didn't know why. And uh
and then with military diving, then you
have the problem of, you know, averting
oxygen seizures. And there's a number of
people in the Navy. Frank Butler comes
to mind, Claude Pianadosi, Richard Moon.
There's there's a network at Duke
University which did a lot of the
seminal studies and uh and that of and
they established the dive tables for
preventing oxygen toxicity, seizures,
nitrogen narosis, high pressure nervous
syndrome. So these are all things that
you have to avert like when you're
diving depending on what kind of diving
you're doing. Was the Navy coming to you
to say, "Look, we know this is
happening. Can you help us push the
envelope?"
>> Yeah. Well, I kind of went to them or
they came to me because I'd like
specialized knowledge, but I wrote
grants uh to to really delve into it.
It's unknown why these seizures occur,
but it gives us a lot of insight into
the brain to understand it, right? From
a redux effect, from a neuropharmacology
effect. So the grants that I had were
literally called you know uh
investigating the cellular and molecular
mechanisms of CNOS oxygen toxicity and
they kind of gave me unlike the NIH they
gave me like I had a lot of tools to
play with that were really expensive
that we got through what's called a a
DoD Durup grant and that bought chambers
and microscopes and electrophysiology
equipment and I was it allowed me to
tinker in the lab and in the process of
tinkering we just had some serendipitous
discoveries, you know, with the cancer
things and then just fundamental effects
that happen in cells under high
pressure, oxygen, you know, nitrogen,
helium, different gases and just very
basic uh so the office of navy research
has a 6.1 program and that's like basic
science and then 6.2 2 6.3 and as we as
I progressed in my career I started
working up from you know a cellbased
system to animal models to then it went
to a pig model system and now now
essentially we're doing the rat studies
at Duke with human subjects that get
inside a chamber and there we get
diaphragmatic we get EEG we have a line
going into their arm that goes to like a
mass spec to get like blood gases to do
metabolomics
uh they're working a simulator a flight
simulator they're exercising thing
they're it's water out immersion so
their body's underwater but you get the
the hypovalmic effect of the fluid shift
and things like that to simulate that
dive and then we push them to a seizure
believe it or not so this got approved
through an IRB which is even more
amazing than the Khill study uh but we
push them to an EEG seizure to where we
can see the se and then we decompress so
we look at latency to seizure under
ketosis dietary ketosis or supplemental
ketosis or the combination. So those
those clinical trials, I'm
co-investigator on it because it's being
done at Duke. Uh they're registered
clinical trials on clinical trial.gov.
So you can look at look at that.
>> And these are being funded by the DoD.
>> Uh Department of Defense has Office of
Navy research. They have the CDMRP which
is congressionally directed medical
research program and also NAVC. So this
is uh an ONR project that got spun into
a NAVC project. So naval, you know, uh,
sea command project. So NAVC is more
human studies and then ON&R is basic
science and then some human research.
>> All right. Well, I want to come back and
talk about a lot of these things, but I
feel like we should now kind of get
people up to speed on
>> what ketones are. Again, we we can sit
here and talk about this and take this
stuff for granted all day. You obviously
threw around the term nutritional
ketosis. You've also talked about
supplemental ketosis, sometimes referred
to as exogenous ketones. Let's start
with nutritional ketosis and just give
people um some definitions of um how you
achieve it, how much variability there
can be in a diet to get there, what the
thresholds are, and a little bit about
what's happening physiologically.
>> Yeah. Uh before I before I begin, I want
to direct people to your early blogs,
which I assume are still up on
nutritional ketosis.
>> I'm sure they are somewhere.
>> Yeah. on the delta G, there's one with
exogenous ketones, you know, and our
study we kind of did with the ketone
salts, which increased your uh
efficiency, oxygen utilization. So,
nutritional ketosis, uh the key to well,
let's take a little bit of a step back.
Ketosis, uh I like to start with
fasting. So, when you stop eating,
right, you suppress the hormone insulin,
you mobilize fatty acids for fuel. The
brain's not a good, it can't use the
longchain fatty acids that are stored in
your atapost tissue. So through beta
oxidation of fatty acids in the liver uh
beta o accelerated beta oxidation in the
context of insulin suppression generates
these molecules beta hydroxybutyrate and
acettoacetate and then they spill into
circulation and uh they become largely
responsible for preserving brain energy
metabolism in the context of
uh energy deprivation or carbohydrate
restriction. So and the elevation of
beta hydroxybutyrate or acettoacetate in
the blood in the urine or the breath
becomes a biioarker. So uh for ketosis
so you can achieve ketosis through
fasting through diet through supplements
or uh alcoholic keto acidosis right
that's another thing or diabetic keto
acidosis and we could talk about that in
context and then you have nutritional
ketosis which is eating carbohydrate
restricted ketogenic diet that's
primarily high in fat. The original diet
was 90% fat. modified versions of the
diet are about 60 to 70% uh fat with
higher protein. Now, we know especially
in kids, you restrict protein too much,
you could stunt their growth and have
some issues there. So, clinically, a
modified version of the ketogenic diet
is actually being kind of gravitated
more towards even in pediatric epilepsy.
So, we're learning that protein is
really important and it was
underappreciated, I guess, in the early
ketogenic diets. In the context of
sports, it's extremely important and we
can talk about that. So but still it
remains that uh the ketogenic diet is
the most scientifically researched diet
that has an objective biioarker that
defines the physiological state of being
in the diet and that's beta
hydroxybutyrate above 0.5 mill moles per
liter. So that's clinical ketosis and in
the context of ketosis it has um uh
there are remarkable changes in our
metabolic physiology and the
neuropharmacology of our brain and also
beta hydroxybutyrate has very unique
effects uh epigenetic effects which is
kind of a new buzzword that people are
talking about and we we my student just
finished a project on that um and I
think there's uh it's pleotropic so
ketogenic diets have pleotrop ropic
effects and uh
>> tell folks what that means.
>> Yeah, plyotropic is kind of like a fancy
somewhat nebulous word that basically
means there are multiple mechanisms that
are activated uh biochemically,
physiologically, neuropharmacologically
uh that have beneficial effects. So um
and I can go through the explosion of
research that has occurred on PubMed and
clinical trials.gov, gov. But the
important thing is that uh nutritional
ketosis or therapeutic ketosis uh or
let's take a step back. The ketogenic
diet, some people say the ketogenic diet
is not magical. The kid does nothing
magical in the context of body
composition alterations or fat loss.
That could be there's truth to that.
However, I I I say there's a hard stop
there. The ketogenic diet is indeed a
magical diet in the way that uh it
remarkably changes our physiology and
there's no other diet uh that exists
that can for example manage drug
resistant seizures and it does that
because it profoundly changes our fuel
system, our physiology, our biochemistry
and our neuropharmacology.
>> Let's talk a little bit about that.
You've mentioned it a few times now. Um
so let's help folks understand what's
going on here. So this was first um
identified in kids and if I'm not
mistaken um
>> well adults actually if you go back to
yeah like the Mayo Clinic in 1920s
because there was no drugs for epilepsy
so we
>> so what gave them the idea
>> that hey we've got these people that are
experiencing this awful thing now they
had EEGs back then but they really
didn't know much
>> true yeah they actually did some really
good physiology back in the 1930s4s
underappreciated uh well we knew that
fasting controlled seizures Right. I
mean like that was the first
observation.
>> Yeah. I mean gospel of Mark talks about
yeah fasting I mean there's it's all
over like in the literature fasting
could control seizures. So a ketogenic
diet by virtue of elevating these ketone
bodies which were showing up in the
blood and the urine and even in the
breath. Uh they just understood that
these ketone bodies were somehow
associated with seizure control and we
did not have anti-seizure drugs back
then.
>> And when were these first identified? So
you've got Banting and Best identify
insulin or at least isolate insulin in
the 1920s. So that's really the in my
mind I think of that as kind of the
golden era of metabolism.
>> Um when were ketones first isolated BHB
specifically?
>> Yeah, just uh within a decade around
that time. So yeah, so around with
Banting and Best uh kind of discovered
it in the context of diabetic keto
acidosis and then work at the Mayo
Clinic by Wilder and a few other people
were helping uh sort of established the
framework for what would be ultimately
the first ketogenic diet kind of kind of
therapies. And the thing was just eating
like all fat. And then we realized we
got to titrate in the protein to prevent
protein malnutrition. And then there was
a tiny in 1921
there in a clinical it was just like a a
a side note on a on a clinical journal
there was the first observation or
clinical report of a ketogenic diet you
know used in epilepsy and the remarkable
effects and we didn't have anything to
we didn't have
>> and they didn't understand why
>> uh they mechanistically I mean we could
go you know a hundred years later and we
don't fully grasp and understand all the
mechanisms involved and that's why it's
such a fruitful robust area of research
right now with drug companies scrambling
to mimic the keto if we had a drug that
would mim mimic the ketogenic diet it
would be a blockbuster drug
>> because if I understand correctly Dom
>> if you take patients if you took a
hundred patients who are drugresistant
so they're having non-stop seizures
despite all the best available
pharmarmacology my recollection this
could be incorrect And you can update
this
>> is that a ketogenic diet will completely
cure onethird of them will cause about a
50% reduction in seizure activity for
another third of them while onethird of
them will still be unresponsive. Is that
still directionally correct?
>> Yeah. In the context of pediatric
epilepsy about twothirds will be so it's
that high
>> two-thirds will be
>> twothirds will be uh therapeutic
therapeutically responsive uh to a
ketogenic diet therapy for managing
seizures are are highly efficacious for
managing seizures. Twothirds of people
who have failed drug therapy and not
we're not just talking about one drug
we're talking about polyfarm pharmacy
adding multiple drugs like you know uh
the list goes on.
>> And what about adults? Uh so in adults
it's more about closer to
post-adolescence about 30 to 40%. Uh but
then it's thought that at adherence and
compliance right with adolescence with
kids the the parents feed you know
usually a ketogenic formula and
calculated out.
>> Uh but there's also something about the
pediatric brain that's probably more
responsive. And then of that 2/3 about
onethird have like uh complete like
seizure control like more than you know
95 to 100% seizure control and then like
10 to 15% and this really interested me
uh when I went to the first conferences
back maybe 15 years ago were super
responders meaning that they could get
on a ketogenic diet follow it for a year
or two transition off and never get
seizures again.
>> Wow. So that so they talked about the
ketogenic diet being curative and that
was really interesting to me. Of course
the brain is changing as you go through
development but it was shifting brain
networks and network stability uh you
know suppressing inflammation and
changing neurotransmitters in a way that
was there's the kindling effect with
seizures. So seizures beget seizures. So
once you have a seizure uh you're more
likely to have another seizure. So if
you control seizures and you do it
through a protracted time frame, even if
you had it's going to lessen the chance
of you, it's going to decrease that
kindling effect. So um so there's
something going on there and we've
replicated that just throwing you know
sodium beta hydroxybutyrate into a
hypocample brain slice preparation under
different levels of you know things that
stimulate seizures like measuring
seizures in a in a slice with like the
orthodromeic population. uh you can
stimulate and measure the orthodic
population spike of the neurons like uh
firing back and then you can decrease
the amplitude of that over time and
essentially just silence seizures in a
slice and at the same time you're making
that hippocample brain slice more
metabolically resilient. You could throw
different agents at it that would be
neuro degenerative or you know uh
hyperexitable and it will protect it
under the context of various
neurotoxins.
So uh so that I think that that really
interested me. So the early observations
and then I was completely unaware of all
this literature in my posttock and then
when I started delving into it I was
like I have to change the trajectory of
my career to do you know to to just but
I'm going to do it in an innovative way.
I'm going to study the ketogenic diet,
but also in parallel or in tandem or
maybe in some cases exclusively just
delve into what is the most efficacious
form of exogenous ketone we can use and
how can we can it augment the
therapeutic efficacy of a ketogenic
diet? Like there's a lot to unpack here
and nobody was doing it at the time.
>> You've obviously experimented a lot with
a ketogenic diet yourself. I mean when
did you first try a ketogenic diet? like
the clinical ketogenic diet where I got
the little cardio check meter which was
super expensive at the time. I would say
2009 I started actually checking ketones
and uh and the cardio they still had
this cardio.
>> I was using the Abbott one.
>> Yeah.
>> Precision the precision. I got that
later. I don't even think that might
have been out yet, but I got that soon
after because the cardio check actually
did like your HDL and like triglycerides
and things. It was a little bit. We
compared it to uh we also had like an a
lab assay like an Eliza assay. Yeah. We
were comparing it to it. Uh yeah. And
then we got uh the the precision extra
by Abbott. And then I remember I bought
something like $10,000 of strips.
>> I was about to say the strips were $5 to
$10 each.
>> Yes.
>> At the time
>> I found uh I bought them in bulk and I
think
>> Yeah. You hooked me up at one point and
we were able to get them for like a
$1.50 or something. I was going through
three a day. Yeah.
>> Yeah. So, uh that price point has come
down, but now we have the Keto Mojo
which is actually uh aligns more with
our assays and and it does the glucose
ketone index that we can talk about. Uh
yeah, so I started doing that and I have
to when I started it within I guess 5
years after starting the ketogenic diet,
I probably rapidly lost 10 to 15 pounds
and then my my exercise and my lifts
tank too. Like I lost strength on bench
press and not so much deadlift and
squat. But I saw that but I didn't
really care that much at the time. But I
also learned the lesson that protein was
really important. I was thinking ketones
would be basically save you know muscle
and but they don't they have an
anti-catabolic effect that we can talk
about but there's nothing you know if
your protein goes from like 250 grams a
day to like you know 70 to 80 grams a
day you're going to lose a lot of muscle
and the ketones have
>> just don't tell the USDA that or you
know the the RDA they still want you to
believe that 08 grams per kilogram uh is
all you need
>> it's very context dependent right to I
was kind of in the gym and I was even
training with legally facitious. I mean
these these guys are out to lunch and
they just can't seem to they just want
to cling on to this idea that protein is
bad.
>> Yeah. I they're avoiding like uh work
from Donald Layman and Stu Phillips and
guys I think you might have had on the
podcast, right? So uh yeah, I learned a
lot of lessons. I learned that uh uh
clinical ketogenic diet skyrockets my
LDL and APOB and that's an I've learned
how to manage that pharmacologically. I
have a mutation for the MPC1L1 receptor.
So, a tiny dose of a zettoide brings
that down. But most importantly, I
realized that titrating the protein in
to meet whatever to to meet, you know,
your your needs for protein. And if
you're an athlete, if you have a high
metabolic rate, if uh you're trying to
gain muscle, you know, you do have to
leverage protein and that becomes the
key factor. I think the key variable in
getting the ketogenic diet to work for
you and also tracking your lipids is
really important.
>> What do you think are the most common
mistakes people make when they're trying
to um uh enter nutritional ketosis? What
what would be the top three or four
mistakes that people are making?
>> Yeah. Not tracking. I mean, people do
it. They're just like, "Oh, I'm just
going to eat, you know, this or that and
not try." It's like, uh, no, you need to
like just write. You don't have to do it
every day, day in and day out, but you
know, use a good tracking metric. Uh,
Carbon app is great. I know you've had
Lean on. I've used that.
>> And there's other apps out there. The
>> app tracking because you want people to
be able to correlate the blood levels
they're seeing with what they're eating.
>> Yeah. So, the macronutrient uh ratios
and the composition, but also the total
amount of calories, which at the time
when I get into this, no, everybody was
said, you know, if you do ketogenic
diet, you don't have to try calories.
Calories don't matter. But we know
that's like I just knew that was BS to
begin with because there are some people
who can easily overeat on a ketogenic
diet. You know, I could sit down with a
bag of of macadamia nuts and polish the
bag off or sour cream or heavy cream or
whatever. So, it's easy to do. So, yeah.
Uh track total calories, macronutrients,
track your blood ketone levels. Uh you
could do urine or breath, too.
>> Are there what what is the
state-of-the-art on urine and breath
meters these days? Yeah, I I you know,
with the breath meter, I do think that's
pretty legitimate because breath acetone
correlates with seizure control. There
was the Biosense device, but uh they've
kind of fallen out of favor. There's a
device called Keto Air that's pretty
good. It's a small, it's like the size
of a pen,
>> and that actually correlates really well
uh with some of the blood ketone
measurements. I do notice that if I'm in
a calorie deficit, my blood uh ketones
are can be very low, but my breath
ketones are high. And I think your
ketone production that you're measuring
is a consequence of ketone production
and ketone utilization. And in the
context of uh an energy deficit, your
tissues are sucking up ketones out of
your blood fast, but you're blowing off
more uh acetone. So your your blood
ketones are and I think you maybe made
some observations of that too with with
differenti you know under
>> also under high utiliz under high
exercise low like normal exercise
supernormal exercise fasting etc.
>> Yeah.
>> Um and then urine uh people I I mean do
>> people still use it.
>> Yeah. But but you know my my view back
at the time was I was never going to get
better precision than using blood.
>> Yeah. blood's still the gold standard
and there's a lot of uh uh and then you
have interstitial right so I just
switched out I was wearing a continuous
ketone monitor and
>> how many companies make those now
>> well Abbott makes one I can't use it
because they use test flight software
and I have an Android I'm the guy that
has the Android uh so I can't use that
but uh I've sort of done you know uh I
been involved with the company a little
bit and just you know had some calls
with them I know I think you have maybe
two involved with them. Uh, but there's
a company
>> I have no involvement.
>> Okay. Uh, yes, but just disclosed, I
don't get paid by them or anything, but
there's a company that's in China and I
think now they have a footprint in the
US. They're called Sai Bio.
>> And I am very impressed with Sy Bio. So,
the first week the ketone measurements
are very accurate, but the last week
they tend to measure about only half of
what you measure in blood.
>> So, it's a it's a device. Is it micro
needles or is it a long filament? looks
exactly like a CGM device. Uh, uses
essentially the same technology, just a
different enzyme. And, uh, you know, I
could swim all day in salt water. I can,
you know, do stuff on the farm. I don't
knock it off. I It's like probably as
reliable as a CGM device now. It's
remarkably reliable. Uh, the specificity
is good and
>> and it's BHB.
>> It's beta hydroxybutyrate. Yeah. It's
important to uh acknowledge that it's
the D anantimer or the R anantimer of
BHB because there's supplements out
there that are recemic. So you can uh
but yeah I've tested it you know uh
pressure tested it if you will with high
doses of ketones and it it performs well
and so there's emerging technologies. So
the continuous ketone monitor continuous
lactate monitor which is I think it's
going to be lactates and ankome
metabolite.
>> Does anybody have one of those
commercially ready yet?
>> Not commercially ready yet. There's
programs, but I don't think monetarily I
don't think the companies are motivated
to bring it to market. And I think
there's some more testing that needs to
be done. But for example, my colleagues
at the Moffett Cancer Center, you know,
they're like salivating over the the
opportunity to do glucose, ketone, and
uh lactate monitoring especially, you
know, I mean, we see that tumor burden
is tightly correlated with blood lactate
levels. So we use lactate monitoring and
that and if you have an expanding mass
of like metastatic cancer like it just
correlates very nicely and lactate an
metabolite that should be measured.
>> So if mistake number one is you're not
measuring your actual ketone levels and
you're not tracking what you're eating
so you can see the association of hey
when I ate this it went down when I ate
this it went up. Um what are some other
mistakes people make with their diet
formulation? Is it too is is that they
typically airing on the side of too much
protein, not enough protein? Are they
not realizing where carbs are sneaking
into their diet? And and what kind of
guidance do you give people? How many
grams of carbs a day do you tell
somebody? Or do you vary that based on
their activity level?
>> Yeah, taking a step back. So, I view
unlike many people out there, I view a
ketogenic diet as a prescription
metabolic therapy. So that's the world
that I come from, you know, and then
there's like, you know, there's clinical
keto and then there's like internet
keto. So a a and which a lot of people
are following a low carb diet which has
a plethora of metabolic benefits. You
know, you just have to be up on your
blood work and you have to be very
vigilant with tracking, you know, your
biomarkers. Uh but a clinical ketogenic
diet is typically done uh with
consulting or advice or even following
the framework of for example a lot of
books out there by Eric Kasoff uh if you
have cancer Miriam Calamian has a guide
ketogenic diet for cancer. Uh so books
that are out there that tell you step by
step on how to do it. And from a
practical or logistical point of view we
had a small study we ran with Dr.
Allison Hall uh that looked at people
that were just uh they didn't have any
overt pathology but they were just like
take normal people put them on a low
carb ketogenic diet and over the
practitioners tell me that if you
transition a person over four to six
weeks they adhere to it better and you
actually get more favorable health
responses. You don't have a lot of funky
blood work that come back. You know, it
could be the electrolytes with people
that have certain mutations with fatty
acid oxidation disorders. Even ApoE4
carriers tend to like you'll see their
LDL go up and you'll see things like HDL
go down and you'll see they start the
diet and their triglycerides go up. Like
I, you know, I've seen that a lot in
quite a few people and I think there's
some genetics that need to be unpacked
there. Uh in several cases it was people
that were APOE E4 carriers like they're
homozygous. So I think there's something
to unpack there. they just don't uh
metabolize their lipid metabolism is a
little bit different. So I think it's
really important to get blood work,
track triglycerides, track HDL, APOB,
LDL, hemoglobin A1C, insulin levels. I
think I've seen people's insulins go up,
but generally speaking, 90% or 80% or
more insulin goes down. Uh but really
just to um to use there's so many
different guides out there and if you're
doing it to manage a clinical condition,
you should be working with a registered
dietitian that's savvy and the people I
recommend there's advanced ketogenic
therapies and it's a team of people and
it's kind of spearheaded by uh Denise
Potter. She's a registered dietitian,
but she was came from the world of
epilepsy and worked as a conventional
registered dietitian and then
transitioned to ketogenic and now has a
team of a half dozen or more people.
>> But if someone just says, look, I just
want to do this on my own just like any
other diet I might follow. What would be
sort of the guidance you'd give them?
>> Yeah, it depends, you know, why they
want to use it. Uh many
>> Well, I think the most common reason
would be weight loss, right?
>> Yeah, weight loss. Uh so I would say
calories are super important. So just uh
gravitate towards a high protein
ketogenic diet. And if it's just purely
weight loss, I would say high protein,
moderate fat, and then high fiber. So
the carbohydrates that you're getting uh
should be just fibrous carbohydrates. So
you can get 50 to even 100 grams of
carbs per day if onethird of those
carbohydrates are fiber. So that
excludes all ultrarocessed food, even
processed food. Like broccoli is about
1/3 fiber. So, if you go down the list,
there's about I think I have a list of
about 30 or 40 forms of carbohydrates
that are about like one/ird uh a quarter
to 1/3 fiber. So, if you're pulling from
that list, uh you're
>> so you've got you've got all your leafy
vegetables. You mentioned broccoli.
Would carrots be in there?
>> No. No. Broccoli, cauliflower, uh
carrots, no, especially if they're
cooked, they're high they can be highly
glycemic. Uh but avocado,
>> bell peppers. Yeah, bell peppers are a
little bit too high in sugar. They're at
the cut off point. Maybe like a green
pepper or something like that. But
generally things that you'd find in
like, you know,
>> cucumber.
>> Cucumber, yes. Um, you know, uh,
asparagus tomato is tomato. No, tomato
is like a fruit, pretty high in sugar.
>> So, these are things that you need to be
kind of vigilant and there's a lot of,
you know, go-to guides. And that's why I
think it's important to use like a
tracking app, right? And you don't have
to do it like I would never use Oh, I
use it now time to time if I want to
make adjustments. So, um, and and be
very v cuz one thing I noticed
especially using the carbon app or other
apps is that I was like I'm getting
about 3 3200 grams of of or 3200
calories per day, but when I put it into
these tracking apps, it's more like
4,000 calories per day. I,
>> you know, meaning you think you're at
32. Yeah. I always always underestimate
it. Uh probably because just fat is so
calorically dense, right? So the amount
of egg yolks and a lot of fatty fish.
This morning I had like three cans of
sardines. Each can is 20 grams of fat
and 15 grams of protein. And that's so
20 that's 60 grams of fat just from
sardines and extravirgin olive oil, you
know, and that's it adds up. It just
seems like oh this is like nothing. This
is like, you know, it's less than I
would have if I'm eating at home. But uh
it adds up. And I think that people that
are not losing weight or managing
whatever they're trying to manage with a
ketogenic diet, they need to track
calories and simple caloric restriction
or creating even like a 10 or 20% energy
deficit will be the big lever that's
going to cure 90% of what most people
are seeking the ketogenic diet for. And
you could do that.
>> So what's the efficacy then? So what why
do you think a ketogenic diet works? Uh,
do you think it works because under
conditions of caloric restriction, it's
more satiating than diets that are high
in carbohydrates?
>> Yeah, I mean, uh, three, just off the
top of my head, it's, uh, hyper
satiating, especially a high protein
ketogenic diet. It's hypo palatable.
Some people may argue that, but you're
not going to overeat a ketogenic diet
just because it doesn't have the hyper
palatability of a standard American
diet, you know. And I think it
fundamentally is changing metabolic
physiology and brain neuropharmacology
in a way that decreases appetite
regulation. So you know with a higher
protein diet, you're getting higher
GLP1, you're reversing insulin
resistance, you're improving uh fatty
acid oxidation and I think you're
fundamentally weaning your brain off
glucose. So your your brain has is
dependent on glucose with a standard
American and as you're decreasing
glucose availability your brain has a
counterregulatory
dysphoric reaction to that and as it
transitions into ketosis
uh you could avert a lot of this simply
by using ketone electrolytes right so uh
like the stuff that I gave you right so
the key to start so that's you know
electrolytes similar blend as element
but bound to beta hydroxybutyrate
consume that when you start the diet And
that'll largely mitigate two things.
It'll mitigate the electrolytes uh which
you dump a ketogenic diet has a
naturetic effect which means you dump uh
sodium and a diuretic effect. So you
have when you
>> let's talk about let's talk about why
those occur
>> and that's important because these are
the things that kind of really throw a
monkey wrench into some of the clinical
trials when people become you know their
electrolytes and they get dehydrated. So
it's important topic.
>> So when I stop eating carbohydrates and
ramp up my fat. By the way, I do want to
go back to sorry one other point. You
keep saying high protein. Can you define
high protein in this context? You talk I
mean are you talking high by the
standards of the RDA or are you just
saying like you know are you saying like
one gram per pound of body weight? Is
that sort of your guidance?
>> Yeah I mean historically you know 8 to
10 to 12% was used with ketogenic diets.
So, I'm talking about a ketogenic diet
that's 20 to 30% protein. So, that's
considered high,
>> but that's hard for people, I think,
sometimes. I mean, you can obviously
back calculate into that by the
calories, but do you find it easier to
just say, look,
>> keep your carbs at 50 gram and try to
get them from high fiber carbs, get your
protein to x grams, and then limit your
total calories to whatever 3,000 with
fat filling the rest. Um, in other
words, what is it typically working out
to in terms of grams per pound of body
weight in term in protein?
>> Yeah, in protein uh if me for example,
right? So, uh would be upwards of I'm
about 220 pounds. So, that would be uh I
know it sounds crazy, but you know, from
the average RD registered dietitian, but
220 grams of protein. Yeah. So, that
would be the upper end if I'm very
active. I mean today maybe I won't get
that or when I'm traveling
>> but that amount of protein I think uh is
the upper end. I don't think there's any
benefits to go above and be beyond that.
>> And at that level of protein you're not
undergoing so much glucanogenesis that
you're making too much glucose that's
offsetting the ketone process.
>> Yeah. Everybody's a unique uh metabolic
entity. So they're going to have a
different response. But for me
personally, uh especially having eaten 4
or 500 grams of protein, and that's not
I'm not exaggerating there. When I was
in my late teens and 20s, uh that works
for me. That level of protein works for
me. Uh for some people, especially if
they're going to jump from 50 grams a
day or the RDA recommendations to uh and
you want to do that to ideal body
weight. So if you have some
>> because the RDA for you is 80 gram.
>> Yeah.
>> Exactly. 80 grams. You're you're 100
kilos. Yeah.
>> The RDA recommends you have 80 g of
protein, not 220 g.
>> At 80 g, you would not be able to
maintain your muscle.
>> No, not not in my context. No,
definitely not. Uh the more muscle you
have, the more protein, they just have
much higher protein turnover. So, you're
breaking down protein, building protein.
That whole cascade is amped up probably
several times higher in the especially
if you're working out and breaking down
protein, you have a fast metabolism. uh
my recent uh you know resting metabolic
rate showed it was 34% higher. So I
don't you know I don't know give I I'd
have to do further studies but they
thought it was they wanted to redo it
and then they
>> that's even when adjusted for your lean
mass.
>> Yeah. Am I resting? Yep. So uh and I
don't know you know I'm I'm going to
redo it in about two weeks. I was also
off creatine and some other things. So
I'm reloading on creatine just started
and uh and gonna redo that again. But
yeah, my my lean mass is kind of I'm
pretty heavier. So I don't want to throw
that's the upper limit. And I think if
people you can gradually increase your
protein but I'm pro I've been very
vigilant now with my protein especially
after turning 50 that this is important
because things start to your sarcopenia
and the loss of lean body mass is almost
considerably higher you know as you know
like in your 50s and there's different
reasons for that but activity is the
main mitigator for that. So, if you're
providing a stimulus for your body to
grow and maintain muscle, you need uh
protein that's double the recommended
daily allowance. I think if you're
really going to be proactive about it,
>> any other kind of quick dos and don'ts
around things like fruit, berries, uh
artificial sweeteners, how do you think
about all of those things as they factor
into a ketogenic diet?
>> Yeah. Uh, I think fat and I tend to like
I guess carb backload at the end of the
day. I eat no carbs all day and at
dinner I'll have like a salad or
vegetables and then in the evening I
have wild blueberries which have like a
third of the the sugar of regular uh
raspberries, blueberries, wild ones. And
then I have like uh a keto mousse which
is just cocoa powder, chocolate ketone
powder and uh and some stevia or monk
fruit and cinnamon in that and it's has
no effect on my CGM. It actually goes
down. So uh I I found out what works for
me and as long as I am eating you know
fiber if the if the carbohydrates are
delivered with fiber there's really no
uh no glycemic you know counter effect
to that no spiking uh I have a short
list of foods so it's basically you know
berries broccoli
asparagus
dark chocolate like these are things
that I eat every day you know maybe not
the asparagus, but broccoli, berries,
dark chocolate, uh, and salads. And, you
know, that's enough. I'm kind of simple
and I keep things, you know, pretty
simple. I don't like even have, in the
past, I had a desire to have more
different kinds of foods. Uh, I enjoy
that. I mean, we were traveling in
Greece and I'm not going to, you know,
pass up all the great food like when I'm
traveling. Uh, and I ate as much
carbohydrates, you know, as whatever
they were serving me. and I came back
six lbs lighter because, you know, I'm
in and out of the water every day. I'm
walking out in the sun and things like
that. So, actually increasing tripling
or quadrupling my carbohydrate made me
lose six pounds when I come back. And I
was I thought for sure I was eating. I
know.
>> But how did you feel? Did you feel
different?
>> I felt I felt great. Yeah, I'm pretty
metabolically flexible. So I think
that's also a consideration
that if you really delve to into
carbohydrate restriction and your body
is completely fat adapted and it's like
carbohydrates are a foreign substance
and glucose spikes or you're going to
have uh sort of a a pretty big
counterregulatory effect once you start
getting bolining carbohydrates again. So
because you're changing your physiology,
you're changing enzyme. So your gut for
one thing is not going to tolerate that.
You know, just from like fitness
competitors when they diet and then they
finish competition and then they go out
and have, you know, like a cheat meal,
then they're up all night with gas and
bloating because simply if you start
with I mean I could go through all the
different systems, but the GI system
takes a big hit. The liver takes a big
hit. The glucose hitting the peripheral
system can't absorb it. So your CGM goes
off the charts and that can trigger
inflammation. That can alter like gut
microbiome. it's going to affect your
mood. Like these are wild swings that
yo-yo dieters go through. So if you're
low carb, you achieve your goals like
your weight and you want and you miss
carbohydrates, you can slightly just
titrate them back in and just uh just do
fibrous vegetables, just start with
that. And some people can't tolerate
that. But, you know, low fruits, most
people who have like an aversion to
plants or some immune reaction to them
usually can tolerate fruits. So before
we go to the exogenous or synthetic
ketones, I want to now ask you about an
even more uh extreme form of diet, which
I'm sure you get asked a lot about. I
know I do, and I have no insight
clinically, nor do I have any personal
experience with this. Let's let's talk
about this carnivore diet.
>> So I I I realize there are different
ways people go about doing this. There
are some versions that are incredibly
strict where you literally are just
eating meat and nothing but meat. And
then there are others where you expand
that into well you can eat other animal
products you can eat eggs you can have
dairy and things like that. Um but let's
start with just the meat only version of
that diet. Now
first of all what do you think is
happening metabolically? How does one
achieve ketosis with just meat? Because
even the fattest serving of meat, even
if you were eating just ribe eyes, I
don't imagine Well, I I suppose it's
possible that you could get 30% of your
calories from protein and 70% from fat.
So, does it does it produce a ketoic
state as well? Typically,
>> I had a ribeye the other night I think
would hit the keto macros because it was
a lot of fat and I was kind of annoyed
because, you know, there was like less
meat and more fat. But uh yeah, I I
think you can achieve ketosis with a
fatty carnivore diet, especially if
calories are restricted,
>> but you couldn't do it if it was a New
York strip or a fillet. You just don't
have enough fat in it relative to the
protein, right?
>> Uh you could if you were in a caloric
deficit. So if you're in an energy
deficit, right? So your insulin is going
to get like everything is going to get
kind of go in the right direction. So
and that's the issue. Uh I I'm a firm
believer that uh carnivore diets can be
therapeutic for people who have
autoimmune disorders. So that's pretty
clear. There's some people who
>> uh they could also follow a path and do
an elimination diet, but the carnivore
diet is the ultimate elimination diet.
So you're meeting your protein
requirements.
>> You're have enough protein to build
muscle. uh protein has pretty much or
you know um steak and an animal-based
protein diet has pretty much all the
micronutrients. I mean you could argue
you could argue maybe uh vitamin C and
magnesium but you do not see vitamin C
deficiency in people that are on
carnivore diets surprisingly. So there's
some vitamin C in like liver and stuff
too. So if you're eating nose totail
that's not something you have to worry
about. I've seen magnesium trending low
although we don't have the best
magnesium you know measurements but uh
or the blood work for but I've seen uh
magnesium being beneficial for people
because magnesium is something it's you
we get it from chlorophyll right it's
like the central molecule of the of
chlorophyll right magnesium uh and we're
not getting any of that really with a
ketogenic diet or very little
>> I mean you're getting a lot cuz you're I
mean I got a ton I mean I would I had
two salads a day when I was on a
ketogenic diet
>> I'm talking pure carnivore.
>> Yeah, I see. I see.
>> Like they I mean like we're talking
steak and water, right? Like not even
coffee, not even putting pepper on the
steak. Like there are a group of people
who believe that and it's working for
them and they have
>> they have a lot of anecdotal data, you
know, to support that. And I get I get
an inbox full of people that say, "Hey,
look, I had this condition or that
condition. I follow carnivore and here's
my blood work." And I can't argue with
that.
>> Yeah. No, I I I I would I find that
stuff pretty compelling from an
elimination diet perspective. And and I'
I've certainly met a number of folks who
who feel that way. And um yeah, I mean I
I think again it's quite binary. It
either it works or it doesn't. And for
many of these people, they're so
debilitated on any other form of diet
that it's a no-brainer. You're going to
stick with that type of restriction.
>> Yeah. The influencer voice is also
amplified. like Joe Rogan for example uh
had vitilgo and you know that's an
autoimmune disorder and I know people
who have that and uh saying it's the
only thing going on a carnivore diet you
know cured my vitilgo like so I have you
know people that are interested in that
so there's a wide variety of things you
know that it can be therapeutic for
there's a group in uh Budapest Hungary
called Paleo Medicina and I went to
their clinic and they pulled their files
and I saw everything from type 1
diabetes to cancer to different uh
different neurological disorders,
>> you know, and these are all but they're
showing me blood work longitudinally
over time and um could be cherrypicked
the cases, but it was pretty convincing
and they probably have a dozen or more
publications out case series and things
like that. So, uh so there's it's but
it's a form of a ketogenic diet. So I
think that's important to understand
like a carnivore diet is fundamentally
uh if practiced the way they do with
paleomicina where you just focus on
super fatty cuts, fatty fish, fatty, you
know, fatty meats and uh it's a version
of a ketogenic diet and I think that's
why it works.
>> All right, let's go back to
now talk about this world of exogenous
ketones, these supplemental ketones.
Now, you alluded to them already through
the lens of kickstarting a ketogenic
diet, but before we talk about
application, I want to kind of orient
people to the journey you've been on.
>> Um, I was once on that journey with you
being a a regular consumer of all sorts
of these things. Um, I will say lately,
and I when I mean lately, I mean only in
the past 3 months, I recently uh tried a
product uh that I like. I put it in my
coffee in the morning and I believe it
is a
disaster of 13 butane dial.
>> So it doesn't come with sort of the
liver toxicity that I think we should
talk about with respect to 13 butane
dial which unfortunately seems to be
running rampant right now.
>> Um but it's a white powder and what's
blows my mind about it is when you mix
it in water and drink it it's palatable.
It's not delicious, like you wouldn't go
out of your way to drink it, but it is
not horrible the way that most of these
synthetic ketones used to taste. So, you
can just make a shot glass of it and
it's totally reasonable. Alternatively,
it's the creamer in my coffee and it's
fantastic. Um, but let's go way back to
the beginning.
>> Yeah. Yeah.
>> So, circa 2011
>> Mhm. You had
basically only two products you could
consume, right? You had a beta
hydroxybutyrate monoester.
Actually, there were more than that.
There was a ketone salt, which we should
talk about. And you had an accetoacetate
diester. Is that correct?
>> Yep. BHB monoester and and 13butane
dial. Acceto acetate diester. Two
accetoates on 13 butane dial. So, there
are two esters.
>> So, just explain to people. Well, I mean
I unfortunately we have to get into a
little biochemistry here for you to
explain the difference between esters
and salts. And so to everybody
listening, apologies, but if you want to
if you want to understand these things,
and you have to if you want to be a
consumer of them, because everybody is
talking about these things as though
they're the same, and they're
categorically not the same. Um, and most
people have no idea what they're talking
about, and most people who are selling
these things are not being transparent
about what it is you're buying. They
just call everything a ketone.
>> Yeah.
>> So, let's do a little bit of
biochemistry, Dom.
>> Sure. Yeah. Glad to do that. Uh I think
it's maybe even good to step back a
little bit. Uh because if you go to
clinicaltrials.gov and you search ketone
supplement, MCT. So that that's a that's
a 8 to 10 carbon fatty acid that can
convert to ketones. So that's that
that'll come into the conversation, but
I want to throw it. But one of the
original kind of ketogenic substances
was 13b butane dial and I have uh I
think compliments of Ken Ford some of
the MIT reports of you know testing this
compound that from the 1960s and then
there was a report written uh by people
at NASA where they were basically
looking at this as a longduration
spaceflight food 13 butane dial which is
an alcohol it's a dalcohol or a glycol.
So uh it is remarkably ketogenic which
means you consume it and you elevate
beta hydroxybutyrate and uh it's
incredibly stable. So hence you know for
long duration space flight it was reject
oh also it it preserves food. So in the
report they basically soaked they put it
into some biscuits and the biscuits were
like extremely shelf stable. So it's a
hctant which means it keeps uh food
moist and it is it's actually grass
approved to be uh like they put it in
sausage casings and things like that
right so that existed that was 13 butane
dial and I think you know I would say
Dr. there was two people who really I'd
like to credit Dr. Henri Bruningraber
from Case Western and Dr. Richard Vichch
the late Dr. Richard Vch who passed away
a mentor of mine. Yeah. He passed away
like two or three years ago I think.
>> Uh and I remember Dr. Vch saying uh
because I was trying to acquire his
ketoneester for some studies and uh I
ultimately you know used the 13 butane
dial or the monoester beta
hydroxybutyrate for seizures but it
didn't work. And I will I'll pivot and
talk about that. So you have 13 butane
dial was the original kind of ketogenic
molecule and then you have two people
who spearheaded ketone esters. Sorry,
just before we leave that one, you said
13b butane dial elevates beta
hydroxybutyrate. Let's explain how and
why.
>> Yeah, good, good. Okay, so you can
consume 13b butane dial and it's a
precursor to beta hydroxybuterrate. When
you consume it, it goes through the
alcohol dehydrogenase pathway and
produces much like alcohol and you can
elevate BHB with this precursor, but it
needs to be metabolized by the liver.
And when it's metabolized by the liver,
the liver does have to work a bit. If
you consume enough to like jack up your
ketones to three or five millolar for
two or three weeks, you're going to see
your liver enzymes jump up. So, I've
done that with 13. And you have to take
a lot of it. You're talking about 150 to
200 milliliters per day for someone like
me to be in therapeutic ketosis. So,
when you do that, you also you're
generating an aldahhide. So you're
generating
>> and do we think that that's what's
driving up because because let let's
take a step back here.
>> If I asked you to consume
100 grams of ethanol a day y
>> for two weeks your transaminas would go
up.
>> Yeah. Yeah. You see Yeah. I've done that
before.
>> Yeah. So let's let's talk about that. So
So a standard drink is about 15 g of
ethanol. So now I'm going to ask you to
maybe more, right?
>> Yeah. Call 20. We round up 20. So now
I'm asking you to have five alcoholic
beverages a day. And by the way, you
could space that out over the course of
the day and not even get a buzz, right?
But I'm going to give you say five
alcoholic beverages a day
>> for two weeks. You are metabolizing
ethanol with alcohol
>> dehydrogenase
>> and you're going to create all of the
various metabolites. Um and the reason
your trans aminases are elevating is
those enzymes are leaking out of
hpatocytes because the hpatocytes are
injured due to the inflammation that
results from that metabolic pathway. Is
that at all analogous to what's
happening with a comparable dose of 13
butane dial?
>> Yeah, it is. There's a couple things
going on. You drink alcohol, you're
deenergizing the redux state of the
liver and you're generating acetal
aldahhide, an aldahhide molecule which
you know aldahhide damages DNA. It's got
oxidative stress issues that baggage
that comes with it. You're also
generating acetate. When you drink
alcohol, you're generating acetate. And
the brain acetate is actually something
I looked into. It's a remarkable
alternative fuel for the brain. So, uh,
so that's like a lot maybe a lot of
people don't know that, but when you
drink alcohol, you're giving your brain
acetate, and that's we can come back to
that. It's analogous to drinking 13
butane dial is analogous to drinking
alcohol. Instead of generating acetate,
you're generating beta hydroxybutyrate,
another alternative fuel for the brain.
Uh in the intermediary,
>> but do you generate the same amount of
aldahhide?
>> Uh you are generating a beta
hydroxybutyrate aldahhide that is
relatively short-lived, but you can
overwhelm the ADH enzyme. So by if you
drink too much of it you can cause uh
you can overwhelm the enzyatic
degradation and Henry Bruningraber did
some seminal studies on this that he
shared with me some of it's published
they had a they had a ketogenic dog
model that they gave 13b butane dial is
a hypoglycemic agent. So it's a
hypoglycemic agent because it
deenergizes the liver and prevents uh
glycogenolyis and gluconioenesis because
those path those uh mechanisms in the
liver are highly highly energy
dependent. So so that's analogous to
alcoholic keto acidosis. When you have
an alcoholic that's fasting and he
overconumes alcohol, he goes to the ER
because he experiences alcoholic keto
acidosis, which is basically it's, you
know, you have runaway ketogenesis
because you have you're inhibiting
glucanogenesis. Uh, but
>> why can't that patient make enough
insulin in response to the beta
hydroxybutyrate to bring the acidosis
under control?
because the liver cannot uh if you
increase insulin right that insulin is
going to only like you know facilitate
glucose disposal so the main thing is
the liver the liver is like
>> you're saying the liver doesn't respond
to the insulin signal to make less BHB
in that situation
>> and alcoholic keto acidosis
>> it does it doesn't so why does it in the
rest of us
>> like when you and I used to do our
ridiculous 10day fasts and all Do you
still do those by the way?
>> Uh I do like a sardine fast, right? So
I'll do like five day Yeah. two or three
cans of sardines a day and that I get
the same benefits and it mitigates a lot
of the negative effects.
>> Yeah. Yeah. Yeah. So but when we used to
do these 10 and 14 day water only fasts,
um
>> our ketones would actually plateau.
>> Yeah. And even when George Cahill did
the, you know, the seinal studies of
40-day water only fasts, their plat
their ketones plateaued at 7 to 10 days.
And a big part of that was that insulin
is now keeping them in check, right? Any
more elevation in the key the reason the
ketones aren't going to produce a level
of acettosis. Acidosis is is that and
that's why of course kids primarily with
type 1 diabetes can develop keto
acidosis. they don't have the beta cell
uh capacity to offset that rise in
ketones. So this is this this case of
the alcoholic is very interesting to me.
I actually was never aware of this.
>> Yeah. I mean it's you have uh you
deenergize the liver so the liver can't
undergo glucanogenesis and some extent
glycogenolyis. Then you have the
electrolyte balance. You get
dehydration. So it's a constellation of
things. But you know in getting back to
13 butane dial if you consume it and you
consume large amounts of it uh like some
of the early work that was done by you
can overwhelm that enzyatic cascade and
you can start generating you know a lot
of these aldahhide intermediates and
that's maybe not a good thing. So uh so
with 13 butane dial I see like two
problems I think people should be aware
of especially people like maybe that are
elderly or using it for cognitive
enhancement is that you get buzzed on it
and I've I've I know I've probably
consumed 13b butane dial than anybody. I
mean we have we had it in like you know
big 20 liter vials of it and I was
drinking
>> I used to buy it at Sigma Chemicals like
the stuff was dirt cheap.
>> Yeah. Yeah. Uh so I've done experimented
with the recemic and then also with the
um with the RN antimer and kind of the
same thing. Uh it's great and actually I
think it has applications for cancer
because it does have a glucose lowering
effect. We mixed it in with a standard
diet and gave it to animals with
metastic cancer and it suppressed cancer
growth and and put them into keto. So it
has some applications there. Uh but
getting back to the ideal ketone, it's
like it's like it's it's analogous
drinking
13b butane dial to elevate BHB is
somewhat analogous to drinking alcohol
to generate acetone or or acetate which
is a great molecule. I mean
>> Right. But it's a very indirect way to
do it that comes with toxicity.
>> Yeah. So what Dr. Vich and Henry
Burningber did and and there was some
others too involved in in the research.
uh Sammy Hasham developed a glycerol uh
beta hydroxybutyrate esther but they
take uh you can take 13b butane dial and
do a transestrification reaction and add
beta hydroxybutyrate to it or you can
add accetoacetate
to the molecule and when you consume it
you quickly liberate the ketones. So you
get a quick uh elevation of ketones,
beta hydroxybutyrate or accetoacetate
and then the 13 butane dial then goes to
the liver and the pharmacocinetics are
as much as you and we mimicked it
exactly in our lab. You go up you have
an initial peak and then like an hour or
two later you have a second peak from
the 13 butane dial and so it's it's a
nice molecule. I mean it's a nice uh and
I think it's it's dose dependently
potentially problematic. And with the
13b butane dial there's two issues would
be the potential for liver toxicity in
people do that do not have healthy
livers like my liver is pretty healthy I
think and it doubled my liver enzymes if
I take a large dose for two weeks and
then the other thing is if you take a
large dose of 13b butane dial the
narcotic effect in someone who doesn't
have good who is frail who doesn't have
good stability it's going to you know in
Dr. beach's word, it's going to make you
drunk stupid because I was trying to
acquire some of his Esther for something
and I was like, well, I'm just going to
use 13 and he kind of talked me out of
it, you know, and the whole reason for
developing the monoester was to avert
the problem.
>> So, the monoester is beta
hydroxybutyrate with a monoester bond to
13b butane dial.
>> Uh, yeah. Or yeah, 13 butane dial that's
Yeah. bounded to beta hydroxybuterrate,
but you said it in Yeah. So, you could
say it either way. Yep. And why is it
that you don't experience the same
negative issue with that molecule? Is it
because you just consume less of it
because you're getting the one uh you're
you're getting the BHB directly?
>> Yeah, you could take, you know, half the
amount and and get and then the kinetics
are a little bit slower too because you
have to hydrayze the BHB from that and
the liver.
>> And why can't you just consume BHB? Why
is is that not stable enough by its own
other than in a salt?
>> Uh you can. Yeah. So, there's a free
acid and that I tinkered with that
originally with the free acid because
you could buy it and it's super acidic
and it's not very stable in solution and
>> for a variety of different reasons
although you could put free acid needs
to be liquid into like an electrolyte
formulation. So we gravitated towards uh
at the time I was using in my
electrophysi electrophysiology
experiments you can't put a ketoneester
in the bath right because uh it doesn't
it needs to be metabolized by the liver
so you can't put it onto neurons so you
have to use a salt so you mimic you know
the pharmacocinetics of what you get
with the esester so we were putting
sodium beta hydroxybutyrate in
>> and I was thinking okay I'll give this
to the animals but then it was like okay
I'll I have to I was very concerned
concerned with the sodium overload like
you know you know uh hypertension all
the negative effects about salt
>> but all the negative effects about salt
and your listeners may not know this but
most physiologists kind of do that study
it
>> the salt sensitive people or the the
problem with salts and people maybe even
think ketone salts is that when you
consume salt you get hypertension and
some people salt sensitive but that's
specific to sodium chloride so sodium
bicarb sodium citrate sodium beta
hydroxy Butyrate is what I'm talking
about. If you consume large doses, gram
molecules of that, you're not that
doesn't have the same hypertensive.
Something about chloride. So, sodium
chloride. So, you could use potassium
chloride, you know, instead of sodium
chloride for salt. But I but I think
that's an important thing to consider uh
because a lot of people shy away from
ketone salts because it's sodium. But
the salt sensitive sort of hypertension
that you get was pretty much is
associated with sodium chloride. Uh so I
and I was communicating with Patrick
Arnold at the time and we were I kind of
have I was like if I have sodium
chloride but I wanted to get potassium
chloride but I looked I couldn't buy it
from Sigma. It wasn't in the cast
database and nobody had thought about
this. I could like how could nobody have
thought about putting ketones on
different electrolytes? It just wasn't
out there. So, um, so I kind of had the
idea of like sodium, calcium, potassium,
uh, magnesium, you know, so there's
different things that you can combine.
>> So, you just needed a positive cation.
>> Yeah. And I wanted to balance the
potassium uh, the sodium with potassium.
So, that was my original thing. I was
like, I was going to create a ketone
salt and just balance the sodium with
potassium.
>> And are those covealently bound or not?
You don't bound. Yeah.
>> Ionically bound. Okay.
sodium's trying to get everybody back to
high school chemistry. Y
>> you can either take this highly highly
acidic BHB molecule and you can
covealently bind it through an esther to
13 butane dol
>> or you can say let's be done with that
baggage of the 13 butane dol and let's
have um uh let's have a non-coovvealent
an ionic bound to a salt and I just need
a positive charge to offset the negative
charge. Y
>> so then you were saying okay I want to
do sodium cuz I can do a lot with it and
then tell me where the potassium comes
in cuz you want sodium and potassium two
both of them are two positive charges
instead of one calcium or one magnesium
which have two positive charges.
>> Yeah. So the idea is to have monovalent
and dvalent cations ions and you can
spread the beta hydroxybutyrate out to
create like a quad salt was the idea
that back in 2011. So reaching out to
Patrick you know is like it wasn't in
the cast database no one had thought
about it. it wasn't you couldn't buy it
so we had to make it right and then we
made the calcium and the magnesium and
through time basically we settled on a
ratio of sodium potassium to calcium
similar to element so they're kind of
ahead of but element is you know sodium
chloride so uh uh keto start or from
audacious nutrition is sodium beta
hydroxybutyrate it's got you know and
the calcium and it's got a spread of
electrolytes that are similar so you're
giving electrolytes and also giving
ketones and that's really important when
you start a ketogenic diet because
you're replenishing
the the electrolytes that you are
spilling out more through a naturic
effect especially the sodium and also
there's an energetic gap in the brain
when you start a ketogenic diet where
you have you know u uh an energetic need
for the increase in ketones so that had
that becomes
>> that's important for people we should we
should go back to that Don because I
think a lot of people
>> have lived bad experience and they don't
understand why, right? Which is in the
early stages of a ketogenic diet,
especially there's there's little room
for error where as glucose levels are
going down and ketone levels haven't
come up enough to fill the gap, you
really feel lousy.
>> Yeah.
>> Um and and again in in retrospect, uh
you you can work around that, but it's
easy to miss it. and meaning it's easy
to miss the mark and therefore suffer
that that that painful transition which
can last weeks in some people um and
therefore using these exogenous ketones
can be a very elegant bridge through it
so that you don't experience the
>> the the the negative side effects of the
transition.
>> Yeah. So you have the energetic effects.
If you do a FG PET scan, you're going to
see like less brain glucose, you know,
utilization for one thing. And then you
have uh with the keto you have the
contraction of plasma volume because as
you lose water and electrolytes so that
you might have orthostatic hypotension,
you just don't you get the brain fog and
then you have electrolytes which are
literally like molecules that are
involved in action potentials in keeping
membrane potentials in cells. So uh and
all these can be kind of mitigated
through u you know uh ketone salts uh h
have an advantage over the ketone
esters. They also have the advantage
because the mineral delays gastric
absorption. So when you take a dose of a
ketone salt it does not cause an insulin
effect. If you drink a ketone estester
or a large dose of 13b butane dial and
I've done this before and you do an
insulin measurement, you know, an hour
after that's you're going to see your
insulin levels increase.
>> How much would you see an increase in
you?
>> So the increase seems to be proportional
to the differential. So if you rapidly
increase ketones 2 millmer and if you
stay under 2 millmer then you don't get
the spike in insulin. But if you consume
it and you get above 1.5 to 2 millmer,
at least in me and a few other people
that did this, then you see this counter
regulatory dump in insulin. So, and that
would also explain when people drink a
large dose of a ketoester, their glucose
levels go down. And it's a bit of a
scary situation because I know people
have gotten themselves into the
situation is that when you drink the
ketoester
about two hours later or thereabouts,
you can be hypoglycemic and also
hypoctootic, which means your ketones
come up, you utilize them as fuel, but
you've released insulin
peripheral glucose disposal, and then
you get into a point where you're
running, for example, and then you tank
because you don't have and you can it
could trigger a headache. it could I
mean as it does with me uh if you take a
large dose so there's ways around that
>> but you're saying the salt produces that
effect much less
>> the salt does not produce that effect at
all so for a number of different reasons
I think uh it's not the rate of rise of
ketones in the bloodstream seem to be
the predictor of if you're going to
release insulin for one thing and then
there's something about the electrolytes
too that maybe delays gastric absorption
and with the salts you're just not
getting that elevation of ketones that's
as high and as rapid as you would get
with a ketoneester. So these are all
things that can
>> So in the packet of the the one that
what's the brand that you brought for
me?
>> Uh Audacious Nutrition Keto Start.
>> Okay. So in that packet you're getting
about how many grams of electrolytes?
About one gram total.
>> Yeah. Total about one gram like sodium
then calcium, magnesium, potassium.
Right. And you're getting uh so there's
different formulations the original
formula so the packets are a little bit
smaller about the size of element now
but you're getting about 6 to 10 grams
of pure beta hydroxybutyrate minus the
electrolytes. So a lot of people that
say you're getting this amount of
ketones that also includes the
electrolytes. So you're getting, you
know, depending upon which packet you
take, 6 g or 10 g of pure beta
hydroxybutyrate and the two different
anantimer. So that's another thing that
we could talk about too. Uh so ketones
>> equal mix of R and D.
>> Uh yes, a 50/50 ratio of D and the L
and RNS,
>> right? So um you know, I guess you could
say there's four different ketone
molecules. There's D beta
hydroxybutyrate the L or the RNS if you
use that nomenclature and then you have
the accetoacetate and beta
hydroxybutyrate does need to break down
to accetoacetate to be used in the
mitochondria and then you have acetone
which has some interesting signaling and
metabolic effects surprisingly. So it
also correlates really well with seizure
control. So we're not I'm not forgetting
about acetone. Still, it's like,
>> so in somebody my size, 180 lbs, 10
grams of BHB will take me to what level
for how long?
>> Yeah. So,
>> and rest, let's just say I'm not
exercising.
>> For me, maybe we can include it in the
show notes. I could show you my uh uh my
CKM, my continuous ketone monitor, and
>> shoots me up for I guess it's about 4
hours, like one packet, four hours.
>> But you're starting at a high level. I'm
at zero, right?
>> No. Well, I would eat carbohydrates to
make sure I'm zero to start with and I
did it under I've done this dozens of
times, but I it's interesting. If I'm
sitting in my car and driving, I had a
road trip and I drank it and I had my
CKM on. It was elevated for like four to
six hours and I was like super like
hyperfocused driving and it was great.
Like
>> elevated like one to two.
>> Uh yeah, it was about one Yeah, between
one and two which I think is an ideal
range because you're not stimulating
insulin. uh a 10. Uh so and interesting
is that uh keto start is D and the L and
it was only measuring the D. So uh but
it's not accounting for the L or
accetoacetate or acetone, right? So it's
a 50/50 mixture of D and L, but it's
only measuring the D and it's still
getting between like one and two miller.
>> Does that mean you're actually at twice
that level?
>> Potentially. Yeah.
>> What were we doing with our Abbott
finger sticks?
>> Measuring D beta hydroxybutyrate. So
does that mean every time we were
measuring this we were probably only
capturing half what Cahill was capturing
or was has everybody always measured
half?
>> No. Well okay so recemic ketones were
some of the first ones to come out on
the market and then everybody gravitated
to the D animer.
>> I think we should stop Dom and explain
to people what the hell we're talking
about. I don't think people know what an
antimer are.
>> Okay. Uh so beta hydroxybutyrate is
produced in the body primarily uh in the
form of d beta hydroxybutyrate
which is a form uh the mirror image of
beta hydroxy of d beta hydroxybutyrate
is L beta hydroxybutyrate
so we say if a if a beta hydroxybutyrate
supplement is recemic it has D and it
has L in it so I think of the
>> let's go back to what you said a second
ago because I want to make sure
understand the mirror. It's literally a
mirror image. So for example, alulose is
an anatimer of fructose. Yeah.
>> Right. So if you hold if you draw
fructose and you hold it in the mirror,
what you see is not fructose. It's the
reflection of fructose. But that's
alulose.
>> Alulose is not an anantimer. It's an
epimer.
>> It's an epimer.
>> I always thought it was an antimer.
>> No, it's an epimer. So it has a Yeah,
>> it has it has another flip.
>> Yeah. Yeah.
>> Oh, okay. So it's two flips. It's it's
similar to an anime but it's an epimer.
>> Uh the I think an important thing to
remember is that like you have like
ringer's lactate which is also dlactate.
So you could I mean maybe analogous
>> but why does this matter chemically? I
think this is the point I want to make
to people is when you when you have a D
and an L of something do they behave the
same?
>> Yeah. So uh I'll get it's not so there's
also u there's a lot of recemic
compounds. So statins, aderall,
ibuprofen. So these are all recemic
mixtures of the same molecule. So
recemic beta hydroxybutyrate you have
the D the D beta hydroxybutyrate gets
metabolize like l like very very fast.
So it gets in your system your tissues
suck it up you metabolize it you do make
your body makes very small amounts of L
beta hydroxybutyrate with a rasmise
enzyme. That rasmise enzyme is not in
the liver but it's in the tissues. So
that that's very interesting because I
think some tissues are converting D to L
to maybe use the L beta hydroxybutyrate
as a signaling but I'm just speculating
but nonetheless you have D gets
metabolized very quickly and then the L
is like a timed release version of beta
hydroxybutyrate. That's how I've always
thought about it even even in like you
know uh Brianna Stubs did some some nice
work looking at the D to L and we've
done quite a bit of work on the D and
the L and the uh a lot of work with
recemic compounds. So the L will get
metabolized like three or four times
slower and you get about 20 or%
conversion of the L back to D but it's a
very slow process. Uh the advantage of
taking the D to L is that or the recemic
when you consume a recemic mixture the
the ketones elevate and stay elevated
quite a bit longer but then you get I
think of the L beta hydroxybutyrate as
an important signaling molecule because
you get higher concentrations of L in
the brain. So if you give someone
recemic beta hydroxybutyrate and then
you pull out you know the heart and you
take samples of the brain out the levels
of of lb beta hydroxybutyrate are going
to be quite a bit higher
>> and is that just because it sticks
around longer and therefore crosses the
bloodb brain barrier or in the case of
the brain
>> it metabolizes slower. So this is
important. We think this is important
because the LBA hydroxybutyrate
>> probably does not have the same it
definitely does not have the same
energetic potential in regards to
generating ATP.
>> It does not.
>> So no V told me that and I'm a believer
that the L because it gets metabolized
much slower.
>> Right. But if you just take the total
metabolism of it, are you saying one
mole of one and one mole of the other
produce a different amount of ATP? Yeah,
they will ultimately L beta
hydroxybutyrate will go into acetal COA
but it'll be metabolized more like a
fatty acid. So where the D gets uh the D
has a redux shift and it causes a
reductive shift. Actually you could have
reductive stress. I'm going to come to
that in a minute. But you have the D and
the L. They get metabolized at different
rates. D gets metabolized slower than
the L takes about three or four times
longer. But the L seems to have
>> sorry you said D metabolize slower I
think. Is it D is quicker?
>> Detabize very fast and L metabolize
slower. Sorry. Uh but the L retains
signaling effects that D does. So for
example the NLR NLRP3 inflammosome,
right? So the nature medicine paper in
2015 doesn't seem to be an antimer
specific. So the D will suppress it. So
that's important because if the L gets
elevated in the brain then it could
inhibit neuroinflammation and
inflammatory processes. So it's like the
almost like the drug form of BHB. Also
the epigenetic effects the signaling
effects and the epigenetic effects of
the L seem to be present too. So you
have the D that gets burned up quickly
for fuel and then the L that kind of
hangs around gets metabolized slower but
then that's hitting the various
receptors. So you have the GP uh GPR
109A receptor and you have you have
epigenetic effects. You have the NLRP3
inflammosome. So you have uh important
signaling functions that ketones are
attributed to and deba hydroxybutyrate
has been sort of spent and used as fuel
but the L is hanging around and actually
uh preserving uh that signaling effect
the positive signaling effect
>> and sorry the continuous ketone monitor
and the Abbott are more measuring D or
L.
>> They only measure uh the D the D they do
not measure the L. I've had
conversations, you know, with them and
uh they don't because
uh even though your body makes small
amounts of it, it's usually just in the
tissue. Uh however, pharmaceutical
companies are the ones kind of that have
reached out and they kind of as you know
there's there's quite a bit of patent
literature that because I was talking
about this like a while ago. So I think
the Buck Institute has like patents on
LBA hydroxybutyrate. There's I would say
there's probably about three dozen
patents on L now because I've kind of
probably attributed to me because I'm
talking about the effects. However, I
think Dr. Vch brought up a good point
and he was right in that the D beta
hydroxybutyrate is energetically
favorable for producing ATP.
Uh but a DL mixture is almost like you
get the benefits of the D, right? And
then you get the signaling benefits of
the L. And we delivered that with an
esther. We delivered that with a with
the ketone diester and that gave us
remarkable results in uh seizure control
in in animal models of cancer. Uh and we
also use the DL salts. So uh so I think
the the industry is kind of coming full
circle. So now you have Lenriched
formulations with D. Uh, but we've
always kind of stuck with the recemic
mixtures because I kind of knew that
there was fundamentally something
interesting about the D and the L
because when I use pure D beta
hydroxybutyrate, it actually trended to
make seizures happen faster and I didn't
know why. Uh,
>> say that again.
>> The when we use pure beta
hydroxybutyrate the dantimer and with an
esther like the monoester.
>> Um,
>> this is when you were saying that Vich's
initial compound
>> Yeah. was your first attempt
>> and it didn't work.
>> Yep. 13 butane dial and then the
monoester uh had no effect on seizures.
So my colleague Dr. Jung Row said you
need to look at accetoacetate and when
you elevate beta hydroxybutyrate and
accetoacetate in a 1:1 ratio that
creates a redux balance and I do think
that's important. Also people have
brought to my attention that when you
rapidly spike DBA hydroxybutyrate you're
causing something called reductive
stress. So you have the the the
production of NADH from NAD and that's
actually depleting NAD. A ketogenic diet
will boost your NAD. Like you could take
uh NAD supplements.
>> That's something that we're working on
too because I think a central mechanism
in ketogenic diets and supplements is
the elevation of NAD. So we're working
with NAD compounds MIB 626 and other
comp I can't talk about that because
it's through an industry but there are
multiple compounds of stabilized NAD
that have interesting and remarkable
effects and we're going to combine them
with various key new ketone molecules
that we're developing. But NAD is sort
of like this hub that is a central
player in the benefits of ketogenesis.
But what do you make of the fact that
there hasn't been any efficacy of NAD
supplementation or even NAD precursors?
So NR and NMN have really not yielded
any meaningful or measurable benefits.
The only thing I've ever seen that
looked
>> somewhat positive was in the trial that
looked at patients with ALS and you saw
a slightly shorter time to ventilator
use with an NR
>> uh formulation. Yeah,
>> but but but really we just haven't seen
any benefits. And so what what do you
what do you attribute that to with
respect to the NAD story? And what do
you think might be missing if indeed
there's efficacy there?
>> Well, uh I mean just I can't say what
I'm doing now, but we're running
experiments I think even today. Uh so
there's different NAD molecules that are
out that are stabilized forms of them
that are in clinical trials. I think
phase two and maybe phase three clinical
trials. Uh and I'm not going to mention
a delivery problem.
>> It's a stabilized. You have to stabilize
NAD. And I think that's important to
have it stabilized because when you
consume it, the liver takes a lot of it.
And if it doesn't,
>> you're not taking enough of it in a
stabilized form, the liver is very
greedy. And uh actually, I think it'd be
good for non-alcoholic fatty liver
disease. So that's another I think NAD
could be uh important for that. Uh, but
I think you have to take a dose that
gets past the liver into circulation and
crosses the bloodb brain barrier and
there's a number of different stabilized
versions of NAD that are in development
and testing and some of them we're
working on that I think have potential
for oxygen toxicity. So, we're working
on those now giving acutely and also
chronically in graded doses.
>> Will will there be other applications
for a DOM such as the holy grail of
Jirro protection or even just
performance enhancement, physical
performance enhancement? Yes. So I am
convinced that some of the animal
literature is pretty I want to replicate
it. So I'm not going to believe
something until I replicate it. So uh so
I think uh we have plans to do some
exercise studies, oxygen toxicity, brain
studies. So um I do think that you need
to give quite a bit of it in a
stabilized form and it needs to get to
the muscle and for me I'm very
interested in it crossing the blood
brain barrier and getting to the brain.
uh I also think that these things will
be more efficacious in the context of
energetic metabolic stress. So for
someone who's already aged where your
NAD level tanks and goes down uh in a
linear fashion like with age uh NAD goes
down but also in the con context of like
traumatic brain injury or shock or and
these are the things that we study. So
I'm not studying NAD as a longevity
molecule. I'm studying in the context of
rare disorders to military like
operational stress, extreme
environments, you know, things like
that.
>> But you have to kind of have to do those
studies and then you glean insights into
that that can then, you know, translate
into the world of longevity. If you're
showing mitochondrial enhancement and
you know preservation because as we age
and we go through different stress
conditions then it's kind of it's
analogous to some of the things that we
study right but I do think I know
there's a lot of buzz about NAD and a
lot of work going on in different I I'm
also very interested in
>> I feel like the buzz over NAD has
largely died actually I feel like people
I feel like it's sort of underdelivered
and most people aren't really talking
about it anymore. I I you know some
people say that with keto right but uh I
went to PubMed right before coming here.
There's 6,000 public uh peer-reviewed
publications on PubMed and over the last
year 717 of them and there's also 558
registered clinical trials on a
ketogenic diet on clinical trials.gov. I
mean you could look at CARTT therapy is
something like this. There's like maybe
four or 500. I mean, so this is
something there's been an experience
>> those spread mostly between cancer,
metabolic disease.
>> Yeah, I actually wrote like uh I've been
on top of this because I've given like
there's 50 CL 40 to 50 clinical trials
on psychiatric disorders. So that
includes bipolar schizophrenia, major
depression, uh anxiety disorders,
anorexia,
uh alcohol use disorders, alcohol
withdrawal, uh traumatic brain injury,
autism, uh
>> anorexia is quite interesting. What do
you think? What do you think is the uh
the hypothesis there?
>> Well, anorexia is uh a psychiatric
disorder. It's the psychiatric disorder
that kills more people. It's the highest
mortality.
So uh yeah there was uh a number of
studies uh Guido Frank he's at
University of San Francisco I believe uh
he's an expert in eating disorders as is
my colleague uh Dr. Deanna Rancort who
kind of has a peripheral like interest
in this but Dr. Dr. Guido Frank is
running a study on anorexia. I believe
from what I last heard, can't talk about
it too much, but I think some of the
data is very encouraging. There was case
reports that combined u a ketogenic diet
with uh ketamine and that put uh
anorexia into remission. And there's
been some quite a bit of buzz about
that. And uh for anorexia typically you
steer people away from any kind of
dietary restriction.
>> Traditional thinking.
>> Yeah. But you have uh the brain the
effects of the ketogenic diet on
neuropharmacology on the hedonic
response on just stabilizing your mood
and other factors that could play into
anorexia seem to be at play. I was super
skeptical because it flies in the face
of everything that I know, you know, and
I've we have one of the leading experts
at
>> University of South Florida, Diana
Rancqu, I remember talking to her about
it and she, you know, kind of was a
little bit skeptical, but the data
coming out and uh looks very promising
and compelling. So, there's continuing
emerging data on psychiatric disorders
largely funded by the Bazooki group, I
think exclusively funded by Jan and
David uh Bazooki, their foundation. And
I think they're funding million-dollar
studies. Six of them that I know. Uh you
have Ohio State University, uh uh
Stanford, Oxford, uh Stonybrook, UCSD,
UCLA, I think Edinburgh, there's a study
too. Uh there's a I'm just looking at
like the different applications. So
they're funding many different studies
mostly across severe psychiatric
disorders.
>> And are they doing this with ketogenic
diets? ketogenic diets plus supplements
just supplements.
>> Yeah. Uh primarily the ketogenic diet
although having served as a reviewer
because they have study section there's
in the pipeline of emerging studies that
they're funding I would say quite a few
studies will be incorporating exogenous
ketone supplementation. So they see that
as an innovative approach uh and a
necessary approach for the feasibility
of therapeutic ketosis because with a
psychiatric disorder it's really
difficult to get someone to adhere to a
ketogenic diet with bipolar with
schizophrenia. I mean it's like a
nightmare.
>> Yeah. So if if an individual says look
I'm I I totally understand why a
ketogenic diet might have efficacy for
weight loss. Um there could be multiple
mechanisms that explain it, but um I
there are undoubtedly thousands of
people listening to us who have no
interest in weight loss. They're they're
they're at an appropriate weight.
They're happy with their weight, but
some of the things you've talked about
might have piqued their curiosity with
respect to performance be let's just
start with cognitive performance. Um,
can you get all the same benefits of a
person who slaves their way through
what, you know, I used to do and you you
do and and and maybe, you know, uh, to
varying degrees do, uh, where you're
you're on this very very strict diet.
Can they get virtually all of those
benefits through judicious use of ketone
supplements?
>> Well, uh, it depends. You know, people
don't like that answer and it's also
very context dependent, but I'll say
this that there are benefits that you
get from carbohydrate restriction that
cannot be replicated with exogenous
ketone supplementation. With that said,
exogenous ketone supplementation tends
to lower blood glucose independent of
carbohydrate restriction
>> indep. What about is it part of the
mechanism that you just described
earlier where look, you ingest enough
ketones, you're going to drive insulin
enough that's going to drive down
glucose, which by the way would not be
the most desirable way to lower glucose.
Well, that's what I originally thought,
right? And uh actually, I do remember
talking with Dr. Vich about this and his
opinion was that you're enhancing
insulin sensitivity and and facilitating
glucose disposal by virtue of enhancing
insulin sensitivity. But I think it's a
combination of different factors. I
think consuming exogenous ketones
uh influences the liver in ways that we
don't understand. So one of uh I are the
next big project that I want to do is
liver metabolomics uh giving exogous
ketones because the liver is the master
regulator of metabolism especially in
the context of everything really
everything that we study. So what I
think is happening is that it's
decreasing gluconioenesis it's decre
decreasing glycogenolyis and also
simultaneously
>> enhancing insulin sensitivity for
greater glucose disposal. However, if
ketones get too high, then you have
competition. The the tissues are
basically uh happy with with ketones and
they probably decrease glucose uh
consumption to some extent. Uh so an
important message that I want to send is
that higher ketones are not advantageous
and I think potentially very
problematic.
>> Define high in that setting. We've
killed quite a bit of animals
inadvertently, you know, in early
studies by putting them into
ketoacidosis with different ketone
nesters. We've never done that with
ketone salts, although we can achieve
therapeutic ketosis with ketone salts or
MCT. So, high ketosis would be in
animals. Once we get above six or seven,
then they start sort of like
hyperventilating. They get sluggish and
sometimes we can't bring them back.
>> Wow. So that has made me a bit scared
about you know some of the ketone esters
and I think some of them are could be in
the bucket of a drug and I think
especially if used in pediatric
population I think that's important. So
higher ketones it's like like we don't
we're not shooting to get our glucose to
like you know 7 8 millmers. So we should
not when you when glucose there's very
powerful homeostatic mechanisms that
maintain glucose under normal
conditions, right? If we're jacking up
our ketones above two, once you get
above two together three, four, and
five, then you're approaching uh energy
toxicity. So you have a level of ketones
in your blood that's producing energy
toxicity. Energy toxicity is defined by
an elevation of a metabolite circulating
in your blood that is causing a number
of things. One is a counterregulatory
reaction which means it's it's
increasing the release of insulin the
secretion of insulin and your kidneys
have to dispose about dispose of that
and our blood gases and blood pH blood
pH will start to go down. Your blood
will become more acidic. That's not a
good thing. And that occurs once you get
above two or 3 mill mo
>> above two pretty much always kind of
above two maybe three in the context of
supplemental ketosis. So if you're on a
ketogenic diet and your glucose is so
low your levels of ketones may approach
three or four because of the glucose
deficiency that you have in your body.
So fat oxidation is so high. It's a very
elegant and finely tuned you know
response that you have uh with that. So
in that context you're presumably in an
energetic it's happening slowly enough.
>> Yeah.
>> That the the redux reaction to balance
your pH is happening. So you're going to
you're absolutely blow off enough CO2 I
assume in that situation if you're
nutritionally at 3 or 4 mill. I don't
remember what my blood gas looked like
but
>> yeah I mean you have respiratory and
renal compensation. Yeah. And that's not
hard at all, right? So for you to do so,
u but if you have if you're consuming
large doses of exogenous ketones, this
is does not apply to the the ketone
salts because the key the salt is
actually a natural buffer, right? So
that's the ionic bond is a positive and
a negative. When you consume large doses
of beta hydroxybutyrate, it's an annion
and you're you're creating an acidic
condition that your body needs to
mitigate through respiratory and renal
compensation.
So, uh, that's I think that can be
problematic especially in people like
purchasing maybe keto nesters in elderly
population where liver function is not
good. They're not very stable and
they're already under metabolically
compromised uh situations.
So, so that's something I think that
people don't think about is energy
toxicity in the context of supplemental
ketones. We think energy toxicity in the
form of supplemental you know uh
calories but uh which is problematic and
in reversing that but but it is
>> so do you think there's any meaningful
application for a BHB monoester these
days given the
>> what is the application for that in your
mind?
>> Well I think it's it's context dependent
but I think these things can be given
you know orally or IV in the context of
acute situations. So I'm in favor of uh
ketone esters and more potent ketone
molecules for medical applications
quickly elevating ketones under for
example status epilepticus traumatic
brain injury like uh blast injury
>> but I thought you said they didn't work
well in epilepsy
>> it depends no I'm talking about maybe a
ketone diester of accetoacetate which we
use so okay so the monoester
>> yeah I'm talking about the original
>> the original molecule from from NIH that
was a monoester of BHB
>> I think they can be formulated. So this
comes to a this comes to uh something
that's a gap in the literature and
there's a gap because every company or
university with IP wants to study a
single molecule in isolation. I think
what we need to do is actually formulate
things and that's kind of what we do. Uh
so every molecule will have pros and
cons and caveats and you could largely
mitigate uh the problem with ketone
esters by you know simply mixing it with
MCT. Uh but you're still going to have
the the 13 butane dial issue. You know
if you're consuming that over long
periods of time that is something to
consider. But you can also have a
glycerol uh traster of beta
hydroxybutyrate or accetoacetate. We
published uh the title is like novel
ketogenic formula where we had a beta
hydroxybutyrate uh or uh glycerol
triestester. So we're working with those
compounds too. But I but I think uh
yeah, it's very context dependent and
the go-to would probably be the
electrolyte salts just because you don't
want to for the average person if you
stay into that sweet spot of 1 to two
millmer.
>> If you elevate beta hydroxybutyrate in
the blood one millmer that represents a
10% increase of available energy to the
brain.
>> So we know that roughly speaking. So uh
so all these calculations from the AV
difference have been done. So I think
that's important. Lactate is also
something uh to consider.
>> So when you think about the advantages
of lactate for uh alternative brain fuel
and ketone as an alternative brain fuel,
you know, I had George Brooks on the
podcast a while ago and he talked about
how you could probably rescue concussion
patients if you administered lactate
quickly following a concussion. Would
you say the same is likely true for
ketones?
>> Yeah, I think lactate's uh an incredible
molecule. my early studies in 2004 and
five I think with lactate but the
ketones represented a more viable option
and also had the anti-seizure effects
that we had plus I was inspired by the
work of of of George Cahill and Dr. V
and you know Theodore Van Italy and then
I got steered towards beta
hydroxybutyrate but I think an important
message is that uh formulation is the
key. So you have beta hydroxybutyrate,
you have lactate, you have MCTs cross
the blood brain barrier. So it's a type
of fat that actually can cross.
>> Do you still use MCTs for anything?
>> I think MCTs are great. Yeah, I think
you know I put it I use a coffee creamer
called Keto Brains. It's like alpha GPC,
MCT, you know, theanine has a couple.
It's a mixture of combinations of
things. But when you combine a ketone
salt with MCT, then you have a you have
a formulation that stimulates your own
ketone production while you're
delivering an exogenous ketone. And if
it's a recemic uh DL beta
hydroxybutyrate like ketoart,
uh then you have a sustained ketone
delivery system for you know, you know,
half of the day. So you just dose that a
couple times. Uh but also some of the
problems that we talked about with fast
entry of ketones into the bloodstream
with the ketone esters or 13b can if you
formulate that with MCT which we've
published on that that can mitigate uh
some of the negative effects. So we
don't see you can mitigate the toxicity
at least in animal models from uh you
need to appreciate the the rate of rise
of ketones is that's kind of the trigger
for some of the counterregulatory
effects. So a slow so it's kind of more
like a dosing issue
>> and if you're taking the currently
formulated ketone salt that you brought
um you do not have to worry about the
electrolyte load. So, if you're
consuming three of those a day, that
would be 3 g of additional electrolytes,
which again, based on what you're also
getting in your food, a lot of people
would say, gosh, that's too many
electrolytes. But you're not seeing the
effect because of the lack of chloride.
Yeah, I would say for people that have
like normal physiology, no kidney or
maybe even with impaired kidney function
because you know there's uh keto citrus
is sold. I think a study just came out
with beta hydroxybutyrate citrate for uh
and other electrolytes too for for
kidney disorders but generally no. So I
was concerned that sodium would cause
hypertension and an increase but uh
sodium chloride seems to be the the
major player there. So I would say no,
but also do your blood work. Uh I
haven't seen that and that was one of
the early concerns I had actually it
steered me toward developing something
other than sodium to potassium and
calcium and other so electrolytes are
largely you know uh benign unless you're
above the 10 grams per day kind of
issue. And I think even with sodium, the
guidelines are something like five grams
of sodium per day, like dietary sodium.
But then something just came out that
said like that's should probably be more
like 8 to 10, you know, could start to
be concerned about five. Uh
>> the the guidelines right now, I think
cap it at five grams of sodium.
>> I think a lot of them are recommending
errone in my mind erroneously like two
to three.
>> Yeah. Yeah. depending on what guideline,
but I think maybe the more looser
guidelines saying it becomes problematic
after five.
>> Okay. I want to talk about two
particular applications with ketogenic
diets. Both of which well one of which
you've spoken about a little bit. The
other one we've sort of talked about um
kind of indirectly, but let's let's say
a word about what you think the future
is for ketogenic diets and the treatment
of cancer and then separately for the
treatment of dementia, specifically
potentially Alzheimer's disease, but any
form of dementia.
>> Yeah. uh we had a review come out with
49 authors and the title was uh ketone
metabolic therapy framework for
glyopblasto
uh so there was you know that includes
basic science researchers a number of
oncologists at major cancer centers and
stuff so the gist of that uh that I
think it's really important to focus on
cancers that where the standard of care
doesn't work so advanced metastatic
cancer obviously pancreatic and
glyobblastoma but glyobbl STS has always
been sort of the heart of what we're
studying. Uh and I think the idea is to
make metabolic therapy part of the
standard of care. So the general just
with that review and the senior author
was Dr. Thomas Safe and I know you've
had him on the podcast and uh Tomas Dac
or Dai he was a primary author.
>> Uh in that in that review it creates a
framework that has uh there's so much in
that review. It ended up it was like 200
pages carved down to like 50 pages with
about a thousand references. Right? So
just like short making it super concise
explanation. So the gist of that for
ketone metabolic therapy for cancer
management specifically glyobblasto but
we think similar reviews can be written
for other types of cancers that are
specifically like hot that are highly
glycolytic and have the warberg effect.
So really hot on an FG PET scan. So
above like 2.5 SUVs like on a PET scan
would define it as hypoglycolytic.
Achieve and maintain a glucose ketone
index of 1 to four. So that's the
millimmer concentration of glucose over
ketones. So if your glucose was four,
which is relatively normal and
>> and your ketone levels were one, you
know, which is the entry of that zone
>> where I'm at now. So that gives me a GKI
of four. standard American uh diet
produces of like a GKI of 50, right? Or
40 or 50. So so simply the the
guidelines are one to two but I think
that's too strict. Achieving a glucose
ketone index of 1 to four
>> is the base of the basis of the therapy
and that sets the stage for other
modalities to work. Uh for example, you
could have uh you want to then target
glucose and glutamine with various
drugs. And if we're going to talk about
anti- glycolytic drugs, uh, metformin,
we've done quite a bit of research with
metformin and I think that's a great
molecule could be a synergizer. I also
think of that as a redux and I'll come
to that.
>> But let me ask a point blank question,
Dom.
>> Um, glyobblasto carries with it a
mortality rate of 100%. Y
>> So it's been said that any patient who
survives a glyopblasto has been
misdiagnosed. They didn't have
glyopblasto. I mean, meaning it's just
it's it's one of the cancers that really
gives cancer a bad name. Is there any
evidence that any form of ketogenic
diet, even at a 1:1 ratio of glucose to
ketone, is going to produce a durable
remission in a patient with a GBM?
>> Durable? No, it's not going to cure it.
So, we're talking about the standard of
care does nothing. We're talking about
>> life extension.
>> Yeah. We're talking about doubling
survival, like tripling. And then as we
learn more, so the the ketone metabolic
therapy framework for GBM is like the
first document in a series of documents
that will ultimately be you know version
number three will be
>> are there any AI platforms to like you
know decode the genetics.
>> Are there RCTs that have and and an RCT
when you place full standard of care
versus full standard of care plus
ketogenic therapy? What is the
difference in median survival?
>> Yeah, those studies are ongoing now.
Jethro Hugh at UCLA just published a
study uh at UCLA just showing you know
improve metrics of survival and you know
uh increased quality of life and
different and I didn't get a chance to
it just came out a paper just came out
so that research is ongoing. I'd say
there's at least a half dozen clinical
trials in progress now and there's
problems associated with those clinical
trials that I could get into that
prevents us from getting to the
question. So the way to like do the
clinical trial is which you know has not
been done yet is to achieve and maintain
a glucose ketone index of 1 to4 like
that has never been done. So you want to
do that and then that is not alone a
ketogenic diet. So what I'm talking
about here is an adgiant to the standard
of care, right?
>> So achieve a GKI of 1 to four, maintain
that and then you go and aggressively
target glucose and glutamine. So you
could target glucose with lonitamine.
It's a hexokinise inhibitor, three
brooyrovate, two deoxylucose,
you can use an SGLT2 inhibitor, you can
use I mean we have about two dozen
different drugs that you could use and
off-the-shelf kind of things like SGLT2.
And then you want to target glutamine
because uh cancer cells will use in you
know you could take glucose out of cell
media and put in glutamine and maintain
cancer cells in glutamine without
glucose. So you want to and certain uh
cells are more adept to use
>> but it's hard to imagine you're ever
going to get glucose to less than 40% of
the brain's fuel which would be which
would be a big achievement right? So if
you if you did all of those tricks,
>> you ramped up ketones, you took glucose
down peripherally to 2.5, even 3 mill.
>> Um,
>> all of, you know, so if you have a if
you have a glucose to ketone index of
1.1 and they're both sitting at 3 mill
>> um, and you're doing all those
therapies, the brain, the neurons are
still getting 40 to 50% of their energy
from glucose.
>> I know. So it's like how But the idea
then is to use like something like
lonitamine, like inhibit hexokinise,
too. So uh there are enzymes glycolytic
enzymes that are upregulated. There are
transporters that are upregulated and if
you create an energy crisis in GBM cells
that's great enough then you trigger
autophagy and then you trigger uh cell
death because there's an incredible
glycolytic energetic demand in
glyobblasto cells and if that demand is
not met then that triggers cell death
pathways. So, but to make inroads into
that and create that energetic crisis,
you have to decrease glucose
availability
uh increase uh decrease circulating
insulin which decreases growth factors
like IGF-1 and and a whole host of other
mTor and other growth factors and then
aggressively target pharmacologically
uh circulating glucose and glycolytic
enzymes. And then you have to
aggressively target uh glutaminolyis
circulating glutamine and also uh drugs
that inhibit glutamine metabolism in the
cancer cells. So you could uh target
glutamine. So there's a drug dawn that
uh that Dr. Seafford uses and I have not
used it. I've talked to some patients
that use it does cause some GI stress.
That's a pretty big heavy hitter. Uh but
you have uh a number of different
things. sodium fennelbutyrate, glycerol
phenol, fennelutyrate, which is actually
an HDAC inhibitor. It will bind up
glutamine and then you pee some of it
out. Uh there's EGCG,
there's curcumin, uh corsetin has
glutamine, glutamines inhibiting
properties,
>> but again, none of this has been
demonstrated clinically. This is all
kind of anecdotal, meaning we don't have
evidence in a clinical trial that this
works. We're we're we're sort of
extracting mechanistically from what we
think these things do.
>> No RCTs. So there's cell data, there's
animal data, and then there's like uh
>> so what's the hold up? Right. I
interviewed I interviewed Tom 7 years
ago and we had this exact same
conversation. Why do you think for
especially for these cancers that have
that are basically just killing machines
like they just they they kill people are
dead within a year of diagnosis.
Why why is it so hard to do these
trials?
>> I understand your frustration. Yeah, I'm
super frustrated. That's what motivates
me kind of to work. But the I would uh
encourage people to read that framework
of the ketone and then look and it's
really important to access the
supplementary uh information which gives
all the different drugs and everything.
>> But the problem is oncologists are not
going to read that right. So the people
that are on the front lines that are
taking care of these patients
>> some of them are authors so they they
they have read it. Yeah.
>> But but again what they want and what
they need is a clinical trial that says
this stack of interventions is going to
double
>> median survival. So if someone came
along and said, "Look, we're going to do
all the things. We're going to rub
curcumin on people's testicles and do
all the things that are anecdotally
supposed to help and it takes median
survival from 11 months to 27 months.
Wow, that's huge. Oh, and by the way,
it's going to reduce the burden of
seizures and it's going to reduce the
catastrophic, debilitating side effects
of this tumor and its therapy. I mean,
it's going to become the standard of
care, but the trial has to be done. The
trial has to be done. It can't be these
sort of oneoff cluji like off in the
corner little nonsense trials that
aren't getting attention right. So why
is that?
>> So we have to you know ask the question
who's going to fund this clinical trial.
So they have the policy makers and the
people at the foundations, people at the
the federal government, the NIH, the
DoD, they fund uh cancer. They have to
be convinced that this is going to work,
right? Uh that ketogenic diet uh and
that we're not we're talking about
something way beyond the ketogenic diet
here. We're talking about a very
comprehensive calculated metabolic based
intervention that targets
>> diet, glycolytic drugs, anti-glutamine
drugs, and then there's a redux
component too. So it's synergized with
with different drugs. So that could be
uh you know hyperbaric oxygen therapy
but uh radiation and chemo kill cancer
cells through oxidative stress. So and
then uh another thing to so where the
money is actually kind of or the
interest is going now is that the the
focus has been using ketone metabolic
therapy as an adivant for like mafet
institute carti therapy for lymphoma. So
they have that project but we just
working on some grants for ketone
metabolic therapy and it's strictly
their focus on beta hydroxybutyrate
because that correlates with the
adaptive immune response that will
augment uh checkpoint inhibitors
specifically PD1 inhibitors and CTLA uh
for uh checkpoint inhibitors. So and
also the ketogenic diet uh expands it
can expand the CARTT cells too. So that
because of that observation and that
correlated with beta hydroxybutyrate
seem to be involved with cartis cell
expansion that became of interest. So
right now the the funding agencies are
kind of focused on augmenting the
standard of care because we already use
the standard of care.
>> But to run a clinical trial with dietary
therapies involves you you have to have
oncologists who are savvy and
knowledgeable about ketogenic diets. You
have to have an RD team. You have to the
inclusion exclusion criteria uh are
really important. The heterogeneity of
many people with brain tumors. I mean
that's like you know something to
consider. Also when you have a a patient
with a glyobblastoma the pharmaceutical
companies are scrambling to get their
drug into that patient. So they are
paying a lot of money to the uh major
institutes to conduct the research to do
you know industry sponsor.
>> Is GBM the wrong model then? Should
should should should all this because
you need a win, right? You got to
demonstrate a win. Should the first one
be pancreatic adno you have far more
patients.
>> Life expectancy is a little bit longer
but it's equally fatal meaning metastic
or advanced pancreatic cancer is
uniformly fatal. Um should should should
we be using that as a model where of
course look all cancers are
heterogeneous heterogeneous rather but
but it might be that GBM is even more so
and it's also heavily impacted by the
radiation like the radiation then
completely changes it virtually all of
these patients are going to need
radiation which makes it even more
difficult. So anyway, look, I'm I I
don't want to offer advice from the
peanut gallery because I'm in the peanut
gallery for a reason on this, but but
that that might be something worth
considering.
>> Um, let's talk about Alzheimer's
disease. So,
>> equally devastating, much longer tale,
>> but in my mind seems somewhat easier to
address through metabolic therapies
because
>> at least in the subset of those patients
for whom an energetic crisis is at the
core and I don't think that that's all
cases. I think it's a I think that's
also a very heterogeneous disease, but
at least one subset of these people are
probably in an energetic crisis. What
what do we know about the current
research and what's the current state of
affairs for using ketogenic therapies?
>> Yeah. Well, uh you're familiar with the
Alzheimer's drugs, right? And you know,
uh there's been not a whole lot of
movement there. We have the antibodies.
You know, you go to antibody therapy,
you're talking 50k at least, you know,
hundreds of thousands of dollars. You
have the potential for side effects like
cerebral hemorrhage and things like
that. And they move the needle maybe for
prevention. Uh a hallmark characteristic
of Alzheimer's disease is glucose hypom
metabolism. So that is actually being
part of the criteria for evaluating. Uh
my thoughts are that in communicating
with hundreds of people with Alzheimer's
and in communicating with people that do
dietary therapies is that there's a
subset of people with Alzheimer's
disease or let's just call it dementia,
right? Because Alzheimer's is still
pretty fuzzy diagnosis, you know, uh
clinically and we have the f we have the
PET scans to look at amaloid and then
there's ptow and and other things. Um
but I think I think it's better to put
it under the umbrella of you know uh
mild cognitive impairment. I think it's
important to focus on that and advance
Alzheimer's disease. So a ubiquitous
characteristic is glucose hypom
metabolism. So uh we are under I've
always been under sort of the the
impression that uh the accumulation of
amaloid and towel are a consequence or
downstream
epiphenomenon
of
inflammation neuroinflammation. Uh
there's of course huge I think there's
like 50 different genes or you know that
can cause Alzheimer's disease. So if
we're talking about APOE4 carrier that's
like
I don't know 80% likely to get you know
advanced Alzheimer's or early onset
two if you have two copies
>> if you have like two or even one copy
>> maybe even a bit less than that but one
one copy is is
>> if you have two copies you are destined
to have it. I mean well
>> if you have there's really only there
are a handful of genes in which you are
destined to get it. Yeah,
>> unfortunately at this point um you know
PS1 PS
if you do nothing
>> but but again I mean you know 25% of the
population are hetererozygous
>> for APOE4 and and they're you know their
risk is twofold higher
>> but but I you know I don't think anyone
would consider that sort of destiny.
>> Yeah, your genes are not your destin. I
don't want to make that
>> sort of assumption but it puts you at
greater risk for sure. So, um I think
you know just taking a step back that we
I think inflammation is the major driver
the more and that wasn't even on my
radar probably the last time we talked
or maybe 10 years ago
>> but I do think that uh systemic
inflammation leads to neuroinflammation
and uh you know we know that if we take
mice or if we take humans or take mice
and inject LPS we can rapidly cause uh
amaloid progression like and so those
studies have been done. So uh
metabolic based therapies, ketogenic
therapies, you know, diet, these things
um not only change metabolic physiology
and brain energy metabolism, but they
change they reduce systemic
inflammation. And I don't know if you
measure your you know inflammatory
markers like HSCRP,
mine is even non-detectable. You know, I
I'll even do things like work out really
hard and go and it's pretty much low. It
only was elevated when I lived in an
undersea environment and was breathing
hypercapnic, you know, under a lot of
stress. But I but I think uh the
advantage of ketogenic metabolic
therapies for Alzheimer's disease is
uh really hinging upon suppressing
inflammation, improving glucose
metabolism and and elevating ketones to
increase uh symptomatically brain energy
metabolism. Uh so I think these
>> of those would you say that the that the
latter is the most important that it's
the alternative fuel source that is the
most important and again let's go back
to I I haven't paid any attention to
this. What's happening in clinical
trials? This is a much easier thing to
test.
>> Yeah. So has someone done the experiment
where you take people in the earliest
stages of dementia or in you know modest
stages of of MCI mild uh cognitive
impairment who are progressing towards
dementia and you randomize them to
standard of care versus the exact same
standard of care plus a KD. Has that
experiment been done cleanly in a
randomized fashion? those experiments
like many things are ongoing and uh and
I think you need you have the acute
effects. So I I think what we can say
that acutely if we elevate ketones in
the context of a cognitive deficit we
can improve cognition under a battery of
different uh exams. But the question
that investigators are after is that if
you do an amaloid PET scan, you know, at
at baseline and 2 years, 5 years, 10
years, that is of the highest interest
because amaloid is basically that's how
you you know that's the prerequisite for
having Alzheimer's disease. So those
studies are ongoing and I'm connected
with some investigators that are doing
it and some that have done more acute
studies and uh the feedback is that I
think there's a subset of people most
people respond favorably but there's
also a subset of people that are hyper
respponders and you can have with
Alzheimer's disease there's like you
know vascular dementia it could be a
blood flow problem it could be excess
glutamate problem it could be a number
of different things that are amendable
to uh being reversed or mitigated
through ketone metabolic therapy. So,
>> so patient selection is going to matter.
>> Yeah, I think it's going to be huge. So,
I think uh and I don't think they've
done this yet is that inclusion criteria
should be patients that uh present with
remarkable glucose hypom metabolism. So,
I think that's that's really an
important key uh because I mean we know
there's people who have brains that are
chuck full of amaloid that have are
completely sharp and are completely
normal. So the amaloid hypothesis has a
lot of baggage with it right. So I think
tal maybe I am amaloid and we have ptow
that we can look at but there's other
things in the pipeline. I think the p75
uh receptor uh agonist or amplifier
looks pretty promising. Those studies
are ongoing.
uh and then you know for prevention I
think some of these things the uh
antibodies do have applications but they
also come with a lot of baggage with uh
not only the cost and accessibility but
cerebral hemorrhage
>> y
>> something you have to have to consider.
So the lowhanging fruit would be a a
dietary or more likely uh with this
population a a an a ketone metabolic
therapy intervention that could be a
ketogenic formula that could also you
know have a number of different
co-actors and other things that can be
but like there's lactate, there's
creatine monohydrate,
there's um you know there's alpha
ketoglutarate but no one as and and this
is a problem with funding agencies. They
don't want to fund a formula. You know,
there's some work done with MCT. Sam
Henderson published in 2008 when the
molecule was AC202. So, but if you look
at the patent, it was just capryillic
triglyceride and actually improved mini
mental status exam and Dr. Mary Newport
kind of saw that and gave her her
husband coconut oil and MCT oil and he
improved and a case report with Dr. Vich
being one of the co-authors on that was
published just a ketogenic intervention
and they followed that was the longest
case report for years followed his
progression and stabilization he ended
up succumbing to the disease but she got
many more years with him you know
through ketogenic intervention so uh I
think we have to you know think about uh
putting together a comprehensive
metabolicbased formula and and Dale
Bredesen has been you know spearheading
some things and looking at more of a
comprehensive approach. Dr. Steven
Kunain has been kind of working on MCTs
and other ketogenic agents for
Alzheimer's. Also did a dual PET scan
where you do a glucose ketone PET scan
and showed and published that you know
as we age our capacity to use glucose
decreases over time but that does not
happen with ketones. So our abil our
brain's ability to use ketones over time
is preserved. Uh so that's an important
distinction and a good uh foundational
framework for the rationale for doing
ketone metabolic therapy. But I think
you'll probably have more benefit by
thinking about it as a comprehensive
metabolic therapy where you can target
different things. And I think you know
there's another a number of different
molecules like alpha GPC but no one does
anything with formulations. They're
pretty much always doing a funding
agency is not gonna ask.
>> What do you think is the state of the
art with alpha GPC just in general for
normal cognitive enhancement?
>> Yeah, I don't it's hard because I always
take it with like something else, but
I've used it by itself and it kind of
gave me a headache when I when I took
it. So, and I didn't really notice any I
think it has the ability to be
beneficial in the context of cognitive
deficit, you know, like many things. And
I do think that ketones are, you know,
listen, everything that we study is in
the context of environmental stress or
some kind of deficit, right? And that's
where ketones shine and they just tend
to work. Uh, but I mean, just speaking
personally, I think they give you an
extra booth boost because they're a
source of energy.
>> What do you think they're best taken
with?
>> Ketones in general.
>> Oh, no, sorry. Alpha.
>> Alpha GPC. Um,
>> I think it works good with caffeine. So
alpha GPC, MCT and caffeine and maybe
theanine too, which is um has like a
little bit of a gabaurgic effect. Uh
that describes a product called a keto
brain. So that's uh a pretty good
product that is kind of a staple product
for me. Uh I ran out of it. I kind of
miss it. So I'm going to reminds me I
have to go buy that. But it's been sort
of what I sip on. I put that into my
coffee and sort of when I'm working on
grants or giving lectures, I just need
long periods of cognitive. But I think
alpha GPC cause maybe a little bit of
too much uh uh just makes me a little
bit too hyperfocused and a little too
stimulated and I think it maybe can
affect my sleep uh too. So I think
people I use that as situationally just
as I use fasting now. So I use fasting
very situationally and that's what I
recommend to people. It shouldn't be
your default. I shouldn't be like, you
know, fasting every day because I think
the more you do it, uh, the easier it
gets. But I think you can actually maybe
derive more benefits situationally if
you have an inflammation event. Like
there's a person, two people that
reached out to me that has shingles or
uh herpes simplex flare up and then they
fast then then it works for that. Or
they have a GI, you know, some kind of
GI issue or some kind of
>> or if they're traveling or for me when
I'm just, you know, bogged down with a
lot of uh paperwork, grant reviews,
writing grants or something, I'll I'll
fast through for half of the day or more
of the day and I'm just sharper, you
know, and just using situationally.
>> All right, let's talk a little bit about
hyperbaric oxygen. Now, you mentioned
and alluded to the fact that there are a
handful of FDA indications for them. To
me, the two most apparent would be
treatment of the bends and obviously for
burn uh for burn patients. So, it
dramatically um aids with wound healing.
>> But there are many things that are
conspicuously absent from any FDA
approval, right? There's no FDA approval
for TBI.
>> There's no FDA approval for concussion.
There's no FDA approval for anything
girrotective.
And yet I've always um said every time
I've done gone back and I maybe do this
every two years. I go back and look at
the data around concussion and TBI
that
you it depends how you look at the data.
There could be a case for it. And you
know patients are always asking me about
hyperbaric oxygen. It's truly one of the
things I get asked about the most. And I
generally tell tell patients it's not
worth the cost. It's not worth the
hassle. it's not worth the
inconvenience. The only except outside
of the approved FDA indications, the
only thing I would suggest going against
the FDA recommendation is if I were to
have a concussion, if one one of my kids
had a concussion, I would probably say
the downside of hyperbaric oxygen is low
enough. I think the potential upside is
there. I think it's worth the risk. Uh
first of all, do you agree with that
statement? If not, modify it
>> in the context of uh acute concussion or
a brain injury. I
>> start with the concussion and then yeah,
talk brain injury after.
>> Uh yeah, in the context of acute like
within the first 48 to 72 hours. I think
hyperbaric oxygen can be remarkably
effective in for kids and for younger
population and probably effective for
adults if early. The jury
>> what protocol would you recommend in
that situation? Yeah, I would well if
it's a penetrating traumatic brain
injury as Okay. Okay. Blunt blunt. We're
not military.
>> Yeah. Okay. Yeah. So, uh I would go with
like standard protocol like two
atmospheres of oxygen, you know, 60 to
90 minutes, 5 days a week. Uh you know,
minimum maybe 3 days a week, 40 40 dives
over that period of time. Um I think
would be could be potentially uh
beneficial. Yeah, that could be
>> that's a hell of a lot. That's you're
talking two months.
>> Yeah, 40 sessions. That's that's like
the most like I mean maybe you could
probably maybe
>> and you can understand why I don't
recommend people do this. Like that's a
that's a job. Yeah, you just basically
decided you're not working for a month
because if you got to drive 30 minutes
each way and you're going to spend 90
minutes in it, that's 2 and 1/2 hours, 5
days a week
>> for, you know, 6 weeks or whatever it
is. I mean, it's that's just an insane
amount. That's it's an insane
commitment. There better be some
reasonable evidence for it. Again, I'm
on the fence on this particular
indication. Um, but that's I mean I I
can't make that much time to do anything
in my life.
>> I know. Uh I mean there are some gyms
that have like the soft chambers and I
think uh we're gravitating that there's
a little more buzz about it about it
with people biohacking.
>> How much atmospheric uh how far can you
get in a soft chamber?
>> Yeah, about 1.3 atmosphere. So, that
would be maybe a good place to start if
you've had u uh you know, if you want to
do mild uh mild if you have a mild
concussion or you want to do more of a a
mild hyperbaric oxygen protocol 1.3
three times per week for like two weeks
or something and I'm just speculating,
but I just I know these people that run
the hyperbaric chambers like I got to go
in for, you know, minimum 20 sessions,
40 sessions. We want to get in for 40.
So I've been a reviewer on a variety of
different publications, systematic
reviews and things like that and been on
top of this field and uh there's some
data that will be coming out from two
different groups uh that suggested that
if you had a traumatic brain injury even
like you know years ago that uh
hyperbaric oxygen increased cognitive
function and pretty much all metrics of
cognitive
uh after that. So that was this protocol
I believe was uh 40 to 60 sessions
uh 1.5 to two atmospheres uh of
hyperbaric. There's also by me we have
this community called the villages and
uh there's a there's a clinic there
called the Aviv clinic and they've
treated like you know they're not
interested in publishing or anything but
they have they've treated like tens of
thousands of patients like at least
10,000 patients and they have convincing
data from what I'm told uh from people
that have worked with them and I've
talked to the director that they have
remarkable you know increase in
cognitive function
from elderly people there that are not
you know they don't have TBI but they
have improved cognitive function across
different and also just like
cardioabolic biomarkers are improving
over time like glucose control I'm a
little bit skeptical on that but I do
see in our animals sometimes they just
go hypoglycemic when we pull them out
>> I was just about to say that glucose
control could be because they're not
eating in the chamber for they're
spending 10 hours a week in a chamber
not eating
>> and oxygen increases metabolic activity
too so especially if you're hype. But um
but yeah, there's you know there's
there's a problem with uh with the
studies that have been done because the
DoD funded a study where they did
hyperbaric oxygen and the control was
hyperbaric air, right? So hyperbaric
oxygen is 100% oxygen, you know, it
increased.
>> So you're still getting hyperbaric
exposure to 20% oxygen.
>> Yeah. So the control was just hyperbaric
pressure and then both groups got
benefits. So uh to there's a lot of
muddy waters. So the DoD wants to put a
nail in this coffin. So they actually
funded my university, University of
South Florida. We have six beautiful
chambers in a facility that's run by the
neurosurgery and neuroscience department
and uh my friend Dr. Joe Dur kind of
runs the facility there. Uh which is
putting putting a nail in this coffin.
So they have subjects with PTSD and also
subjects with with brain injury, but
it's more of a PTSD trial. And they have
a sham. The sham is that they pulse the
pressure during the initial compression
to make you think like you're undergoing
pressure but keep it at one atmosphere
and at the end with the decompress they
pulse it so you you feel a little bit.
>> And then you have people that you know
they'll work with.
>> But why PTSD as opposed to TBI? Uh,
well, it's it's brain injury, PTSD. So,
it's just answering that question
because PTSD is such a a huge problem.
>> Sure.
>> For one thing, as is, you know, brain
injuries, but they kind of across the
board they're treating and the these
chambers, six chambers are active from
morning till night. So it's a $30
million project
>> that that is has all the right controls
all the people involved and uh multiple
institutes are sort of collaborating but
the central location is
>> yeah it's ongoing like
>> and when does it read out
>> uh it will be done I think some
preliminary data should be coming out
within the next year but it will be and
if people do get a benefit from it uh
and they're in the sham group uh or if
they're in the hyperbaric group, then
they'll have the the you know, they're
going to give them access to that. Yeah.
So, it's going to become like a
treatment center.
>> Uh I I was not actively involved in the
initiation of that maybe because I study
the negative effects of fibra, but I've
been like peripherilally involved of it.
I saw I've been inspired by the work
that they're doing and the level of
scientific rigor that they're using to
approach this question of the potential
neuro regenerative and uh cognitive and
just you know even mental health effects
of hyperbaric oxygen which have been
reported anecdotally but have not been
systematically studied in this rigorous
way. So that project is ongoing right
now. But in addition to that, I've
reviewed some papers that'll be coming
out and some some work that has been
done to suggest that
>> if you had a if you had traumatic brain
injury years ago and you go into
chambers that and you use a rigorous
meth method of the only thing is they
did not have a sham control. They did
not have a control. who you know it's
it's hard to do a control but they've
figured out a way to do it at USF and
they have um even like a psychiatrist
come like they have a person that comes
in to question the person uh and figure
out if they're lying or not you know
about the about the control like did you
experience it and basically all the
subjects that are getting the sham have
no idea if they got sham or treatment
>> so no no experiment no protocol that's
gonna be great I've never done that
before and just the sheer amount of
people that are going to be treated. I
think
>> all veterans.
>> Yeah. Yep.
>> Well, that's great to hear, Dom. This
has been um really interesting. I mean,
to me, there have been a lot of things
that unfortunately haven't changed fast
enough since we last spoke, namely
around our insights around cancer and
Alzheimer's disease, largely due to a
lack of clinical trials. But the
unbelievable change in exogenous and
supplemental ketones, it's it's
exploded. you've been leading the charge
in that. It gives someone like me a lot
of hope. I mean, I've long ago given up
on the uh the discipline of a ketogenic
diet. Although I achieved remarkable
benefit from it. Um but but something
just changed when my daughter was old
enough and I just wanted to start eating
everything. Um and that hasn't vanished.
So I'm on the I'm on the seafood diet.
That is e food diet. I
>> You're not managing epilepsy or anything
like that. Yeah. You got benefits of it.
I know at the time like I distinctly
remember going to the gym with you and
the amount of like volume that you would
do or you know just riding the bike and
just swimming and yeah it's just it was
crazy.
>> But I really I you've really piqued my
curiosity about these um exogenous
ketones and and in addition to that one
that I've just started putting into my
coffee. I think I'm going to really give
some of these salts a try. Um especially
given what you've said about the cuz I
you know I'd always felt that well I
need to kind of be somewhat mindful of
of of of electrolyte load beyond what I
already consume.
>> Um and also although we didn't talk
about it I know you and I have spoken
about it just before which was you don't
have the same GI consequences that used
to exist with the ketone salts which
largely limited their consumption. So uh
tell me tell me and tell everybody again
the brand that that you're suggesting I
give a try to that you brought.
>> Yeah. Uh, Keto Start by Audacious
Nutrition is Keto Start. Yeah, Keto.
>> You can buy it online. It's direct. You
buy directly from them. Is it on Amazon?
>> Right on the I think. Yeah, it's on
Amazon. Should be on Amazon. So, yeah.
So, I mean, that's what I use and it's
kind of evolved out of uh, you know, it
was essentially the molecules that we
originally studied and kind of stuck
with even after, you know, looking at
all the different
>> You're not financially involved in this
company? No. Your wife advises them
though.
>> Yes. Okay.
>> So, uh,
>> so yeah, I've been more I I'm on the
sidelines. So, I don't sell anything.
So, I don't have any companies. I don't
say anything. I do advise for for
companies. And we talked about CGM. So,
I'm an adviser for Levels Health. I'm an
adviser for MedSAI, ME TYS.
So, it's uh essentially an app and a
program for metabolic psychiatry and
advised a little bit for uh RX Sugar,
which sold alulose. So, I kind of
disclosed those things. who I don't
think we talked about alulose too much
but uh
>> we got to say something for next time.
>> Yeah. So uh yeah but just I don't I'm
not I don't have any brands or selling
anything but I do have keto nutrition.
So that's myformational website and I
think the big thing that I'm involved in
is uh the well the metabolic link
podcast and that's our podcast that we
want to have you on of course and the
metabolic health initiative which is an
ACCME accredited medical education
platform. So that platform has is
associated with a podcast but we have
educational information where we have
doctors, neuroscientists, cardiologists,
oncologists, you know, doctors that
treat metabolic disorders uh give
lectures on this and so you can get
medical education and learn about
ketogenic met and we have you know
there's uh it's got to meet the ACCME
bar of of standards. So that's metabolic
health initiative and also the uh
metabolic link podcast and also the
metabolic health summit which we've had
many of people that have been on your
podcast have been you know spoken at the
summit. It's a big and that was in
Clearwater, Florida. So, we're
regrouping and figuring out what the
future of that's going to be. But
there's no really experience that you
can mimic than an in-person kind of
event and you can network with people
and we have basic science, clinical
science, and also uh uh a big focus of
it too is having patients talk and then
talk about the implementation strategies
uh with with what we're talking about
here. So, yeah, I'd like to put that on
people's radar. Well, we'll stick all of
that in the show notes so that everybody
can find you and and you're also just
arguably the single most generous person
with this time I've ever met. I I
>> I know that you you personally take so
much time to respond to strangers who
are contacting you and um you know that
is I suppose the burden and
responsibility of being one of the most
knowledgeable people on this planet when
it comes to this type of therapy. So uh
on behalf of all those people, thank you
and thank you for for coming all the way
out here. appreciate taking you. I know
how I know how busy you are.
>> Thanks for having me. It's been my
pleasure. Yeah. Thank you.
Ask follow-up questions or revisit key timestamps.
The video features a discussion between Peter and Dom on the topic of ketogenic diets and exogenous ketones. Dom, with a background in neuroscience and nutrition, shares his research journey, starting with his work on oxygen toxicity and the ketogenic diet's role in seizure disorders. The conversation delves into the mechanisms of ketosis, the history of its use in epilepsy, and its potential applications in various health conditions. They explore the differences between ketone salts and esters, the importance of proper formulation, and the potential benefits and drawbacks of different approaches. The discussion also touches upon the role of NAD, the carnivore diet, and the latest research in cancer and Alzheimer's disease treatment. The conversation highlights the growing interest and scientific exploration of ketogenic therapies and their potential to revolutionize metabolic and neurological health.
Videos recently processed by our community